Louisiana State University

LSU Digital Commons
LSU Doctoral Dissertations

Graduate School

2015

Biogenesis and Redox Transition of Iron-sulfur Clusters in
Proteins
Aaron Paul Landry
Louisiana State University and Agricultural and Mechanical College

Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations

Recommended Citation
Landry, Aaron Paul, "Biogenesis and Redox Transition of Iron-sulfur Clusters in Proteins" (2015). LSU
Doctoral Dissertations. 398.
https://digitalcommons.lsu.edu/gradschool_dissertations/398

This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It
has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU
Digital Commons. For more information, please contactgradetd@lsu.edu.

BIOGENESIS AND REDOX TRANSITION
OF IRON-SULFUR CLUSTERS IN PROTEINS

A Dissertation
Submitted to the Graduate Faculty of the
Louisiana State University and
Agricultural and Mechanical College
in partial fulfillment of the
requirements for the degree of
Doctor of Philosophy
in
The Department of Biological Sciences

by
Aaron Paul Landry
B.S., Louisiana State University, 2010
August 2015

ACKNOWLEDGEMENTS
Reaching the end of my graduate career would not have been possible without several
people, and I would like to sincerely thank them for all the help they have given me in the past
years. First and foremost I thank my major professor, Dr. Huangen Ding, who has always inspired
me and challenged me to hold myself to a higher standard. His guidance and the time he invested
in me have been invaluable throughout my graduate studies.
I thank my committee members, Dr. Sue Bartlett and Dr. Marcia Newcomer, and Dean’s
Representative Dr. Mandi Lopez for their time, patience and thoughtful input on my work. I also
would like to thank Dr. Joomyeong Kim and Dr. John Battista for their insightful discussions on
my work and career path. I also thank Dr. Erin Hawkins and Dr. Johnna Roose.
My accomplishments in the laboratory would not have been possible without the help of
my colleagues. I especially thank Dr. Xuewu Duan who introduced me to my first experiences of
conducting scientific research. I also thank Guoqiang Tan for his help in earlier years, as well as
former lab members Dr. Jacob P. Bitoun, Dr. Binbin Ren and Dr. Juanjuan Yang. I also thank my
current lab members, Zishuo Cheng, Md. Julkernine Julfiker, and Jing Yang for their help in
experiments, insightful discussions and friendship.
Lastly, I especially thank my family and friends for their endless support. I thank my loving
parents, Wesley J. Landry and Valarie S. L. Lucas, who worked hard to help me get to where I am
and always encouraged me to do my best and pursue greater things. I also thank B. Pinithi Perera
for her support and encouragement.

ii

TABLE OF CONTENTS
ACKNOWLEDGEMENTS ............................................................................................................ ii
LIST OF FIGURES .........................................................................................................................v
LIST OF ABBREVIATIONS ...................................................................................................... viii
ABSTRACT .....................................................................................................................................x
CHAPTER 1. INTRODUCTION ....................................................................................................1
1.1 Diversity of iron-sulfur proteins .............................................................................................1
1.2 Iron-sulfur cluster biogenesis ..................................................................................................2
1.3 Iron-sulfur proteins and oxidative stress .................................................................................8
1.4 Iron-sulfur proteins and nitric oxide cytotoxicity .................................................................10
1.5 Key iron-sulfur proteins related to human health .................................................................13
1.6 Statement of research objectives ...........................................................................................19
1.7 References .............................................................................................................................21
CHAPTER 2. IRON BINDING ACTIVITY IS ESSENTIAL FOR THE FUNCTION OF ISCA
IN IRON-SULFUR CLUSTER BIOGENESIS .............................................................................36
2.1 Introduction ...........................................................................................................................36
2.2 Materials and Methods ..........................................................................................................38
2.3 Results ...................................................................................................................................39
2.4 Discussion .............................................................................................................................48
2.5 References .............................................................................................................................50
CHAPTER 3. IRON-SULFUR PROTEINS ARE THE MAJOR SOURCE OF PROTEINBOUND DNICS FORMED IN E. COLI CELLS UNDER NITRIC OXIDE STRESS ................57
3.1 Introduction ...........................................................................................................................57
3.2 Materials and Methods ..........................................................................................................59
3.3 Results ...................................................................................................................................61
3.4 Discussion .............................................................................................................................72
3.5 References .............................................................................................................................75
CHAPTER 4. THE N-TERMINAL DOMAIN OF HUMAN DNA HELICASE RTEL1
CONTAINS A REDOX ACTIVE IRON-SULFUR CLUSTER ...................................................81
4.1 Introduction ...........................................................................................................................81
4.2 Materials and Methods ..........................................................................................................82
4.3 Results ...................................................................................................................................85
4.4 Discussion .............................................................................................................................91
4.5 References .............................................................................................................................93
iii

CHAPTER 5. REDOX CONTROL OF HUMAN MITOCHONDRIAL PROTEIN MITONEET
[2FE-2S] CLUSTERS BY BIOLOGICAL THIOLS AND HYDROGEN PEROXIDE...............97
5.1 Introduction ...........................................................................................................................97
5.2 Materials and Methods ..........................................................................................................99
5.3 Results .................................................................................................................................101
5.4 Discussion ...........................................................................................................................111
5.5 References ...........................................................................................................................116
CHAPTER 6. REDUCTION OF HUMAN MITOCHONDRIAL PROTEIN MITONEET [2FE2S] CLUSTERS BY HUMAN GLUTATHIONE REDUCTASE ..............................................121
6.1 Introduction .........................................................................................................................121
6.2 Materials and Methods ........................................................................................................123
6.3 Results .................................................................................................................................126
6.4 Discussion ...........................................................................................................................137
6.5 References ...........................................................................................................................141
CHAPTER 7. CONCLUSIONS AND FUTURE DIRECTIONS ...............................................147
7.1 References ...........................................................................................................................151
APPENDIX: PERMISSION TO INCLUDE PUBLISHED WORK ...........................................153
VITA ............................................................................................................................................160

iv

LIST OF FIGURES
1.1

Iron-sulfur clusters ...............................................................................................................2

1.2

The iscRSUA-hscBA-fdx-iscX (ISC) gene cluster in E. coli ................................................4

1.3

The proposed USA model for iron-sulfur cluster assembly ................................................6

1.4

ROS generation and oxidative stress ...................................................................................9

1.5

NO modification of iron-sulfur proteins ............................................................................12

1.6

Helicase activity of Rtel1 in telomere maintenance ..........................................................15

1.7

Structure of the type II diabetes drug pioglitazone ............................................................17

2.1

Iron binding of primary iron-sulfur cluster assembly proteins ..........................................40

2.2

L-cysteine-mediated iron release from IscA ......................................................................43

2.3

Location of tyrosine 40 in the E. coli IscA dimer ..............................................................44

2.4

IscA mutant Y40F has a diminished binding activity........................................................45

2.5

In vitro iron-sulfur cluster assembly in IscA and IscA mutant Y40F ................................46

2.6

Complementary activity of the IscA mutant Y40F in an E. coli mutant with deletion
of IscA and is paralog SufA ...............................................................................................48

3.1

Recombinant aconitase B is modified to form protein bound DNICs in E. coli cells
under NO stress ..................................................................................................................62

3.2

Correlation between the amount of recombinant aconitase B and the NO-mediated
formation of protein-bound DNICs in E. coli cells............................................................63

3.3

Formation of protein-bound DNICs in other recombinant iron-sulfur proteins in
E. coli cells under NO stress ..............................................................................................64

3.4

Deficiency of iron-sulfur cluster assembly largely eliminates the NO-mediated
formation of protein-bound DNICs in E. coli cells............................................................66

3.5

Depletion of the “chelatable iron pool” removes iron-sulfur clusters from recombinant
aconitase B in E. coli cells .................................................................................................68

3.6

Removal of iron-sulfur clusters in aconitase B prevents the NO-mediated formation
of protein-bound DNICs in E. coli cells ............................................................................70
v

3.7

Iron-sulfur clusters in proteins constitute at least part of the “chelatable iron pool”
in E. coli cells .....................................................................................................................71

4.1

Alignment of the N-terminal domain of some human DNA helicases ..............................83

4.2

The N-terminal domain of Rtel1 (RtelN) contains an iron-sulfur cluster ..........................86

4.3

Redox titration of the RtelN iron-sulfur cluster .................................................................88

4.4

DNA binding activity of purified RtelN ............................................................................89

4.5

DNA binding activity of RtelN with modified iron-sulfur cluster ....................................90

5.1

MitoNEET [2Fe-2S] clusters are fully reduced in E. coli cells .......................................102

5.2

MitoNEET [2Fe-2S] clusters can be reduced by biological thiols in vitro......................104

5.3

Reduction of mitoNEET [2Fe-2S] clusters by the thioredoxin reductase system
in vitro ..............................................................................................................................106

5.4

Reversible oxidation of mitoNEET [2Fe-2S] clusters by hydrogen peroxide
in vitro ..............................................................................................................................108

5.5

Reversible oxidation of mitoNEET [2Fe-2S] clusters by hydrogen peroxide in
E. coli cells .......................................................................................................................109

5.6

Pioglitazone inhibits the thiol-mediated reduction of mitoNEET [2Fe-2S] clusters .......110

5.7

Proposed model for redox regulation of mitoNEET [2Fe-2S] clusters in response
to biological thiols, hydrogen peroxide, and the type II diabetes drug pioglitazone .......112

6.1

MitoNEET [2Fe-2S] clusters are reduced by E. coli thioredoxin reductase and
glutathione reductase .......................................................................................................127

6.2

Reduction of the mitoNEET [2Fe-2S] clusters by human glutathione reductase ............130

6.3

Reduction kinetics of the mitoNEET [2Fe-2S] clusters by human glutathione
reductase ..........................................................................................................................131

6.4

The redox active disulfide in human glutathione reductase is crucial for reducing
the mitoNEET [2Fe-2S] clusters ......................................................................................133

6.5

The mitoNEET [2Fe-2S] clusters are reduced in the mouse heart cell extracts by
NADPH ............................................................................................................................135

vi

6.6

Hydrogen peroxide-mediated oxidation of the mitoNEET [2Fe-2S] clusters in the
cell extracts ......................................................................................................................136

6.7

Re-reduction of the mitoNEET [2Fe-2S] clusters in the cell extracts after hydrogen
peroxide exposure ............................................................................................................137

6.8

Proposed model for redox transition of mitoNEET [2Fe-2S] clusters in response to
hydrogen peroxide in mammalian cells ...........................................................................140

vii

LIST OF ABBREVIATIONS
AcnB

aconitase B

CyaY

E. coli homolog of frataxin

Dith

sodium dithionite

DNIC

dinitrosyl iron complex

DTT

dithiothreitol

Em

redox midpoint potential

EPR

electron paramagnetic resonance

[Fe-S]

iron-sulfur

Gor

glutathione reductase

GSH

reduced glutathione

GSSG

oxidized glutathione

H87C

mitoNEET histidine 87 substituted with cysteine

hGSR

human glutathione reductase

iscA-/sufA-

E. coli mutant with iscA and sufA deletion

Miner1

mitoNEET-related protein 1

Miner2

mitoNEET-related protein 2

mito

mitoNEET

mT

milliTesla

mV

millivolts

NAC

N-acetyl-L-cysteine
viii

NEM

N-ethylmaleimide

NO

nitric oxide

NONOate

diethylamine NONOate

NOS

nitric oxide synthase

O.D.

optical density

Pio

pioglitazone

PPARγ

peroxisome proliferator-activated receptor γ

ROS

reactive oxygen species

Rtel1

regulator of telomere length

RtelN

N-terminal domain of Rtel1

TrxA

thioredoxin

TrxB

thioredoxin reductase

TZD

thiazolidinedione

Y40F

IscA tyrosine 40 substituted with phenylalanine

·OH

hydroxyl free radical

·O2-

superoxide anion

ix

ABSTRACT
Iron-sulfur proteins comprise one of the most ubiquitous and conserved classes of proteins
in biology. The diverse functions of iron-sulfur clusters in proteins range from electron transfer to
redox signaling. The assembly of iron-sulfur clusters in cells requires a complex protein system
and acquisition of sulfur and iron. While the sulfur source for iron-sulfur cluster assembly is wellestablished, the iron source remains elusive. The first part of this work provides new evidence for
the hypothesis that the conserved iron-sulfur cluster assembly protein IscA may act as the iron
donor for iron-sulfur cluster assembly.
Iron-sulfur clusters in proteins are also vulnerable to reactive oxygen and nitrogen species.
Indeed, iron-sulfur clusters in proteins can be readily destroyed by nitric oxide (NO) forming
protein-bound dinitrosyl iron complexes (DNICs). The second part of this work demonstrates that
iron-sulfur proteins are the major source of protein-bound DNICs found in NO-exposed cells. The
results reveal new aspects of the molecular mechanism underlying NO cytotoxicity.
As dysfunction of iron-sulfur clusters has been implicated in several human diseases, two
human iron-sulfur proteins have been chosen for functional investigation of their iron-sulfur
clusters. The first example is Rtel1, a DNA helicase that regulates telomere length. Rtel1 was
predicted to contain an iron-sulfur cluster, but this was not demonstrated. The third part of this
work shows that the N-terminal domain of Rtel1 indeed contains a redox active [4Fe-4S] cluster.
The second example is the mitochondrial outer membrane protein mitoNEET, a recently identified
target of the type II diabetes drug pioglitazone. The studies show that mitoNEET [2Fe-2S] clusters
can be readily reduced by biological thiols and human glutathione reductase, and is reversibly
oxidized by hydrogen peroxide, suggesting that mitoNEET may undergo redox transitions to
regulate mitochondrial energy metabolism in response to oxidative stress.

x

In summary, the research presented in this dissertation advances our understanding of how
iron-sulfur clusters may be assembled and how NO modification of iron-sulfur proteins may
contribute to NO cytotoxicity. The human iron-sulfur proteins Rtel1 and mitoNEET further
illustrate how iron-sulfur clusters may modulate protein functions via redox transition of their ironsulfur clusters in response to oxidative signals.

xi

CHAPTER 1
INTRODUCTION

1.1 Diversity of iron-sulfur proteins
Iron-sulfur proteins comprise a functionally diverse family of proteins found in all forms
of life. Over 500 unique iron-sulfur proteins have been discovered in various organisms (1), and
many of these proteins are conserved from prokaryotes to eukaryotes. The iron-sulfur proteins are
involved in many critical cellular processes, including photosynthesis and respiration, nitrogen
fixation, DNA synthesis and repair, ribosome biogenesis, lipoic acid and heme biosynthesis, and
regulation of gene expression (2). Iron-sulfur clusters are believed to be some of the most ancient
prosthetic groups in proteins, as iron and sulfide coordination was likely favorable in anaerobic
conditions on the young Earth (3). Minerals containing iron and sulfide may have carried out
primitive redox reactions on the surfaces of proteins that eventually evolved into catalytic cycles,
assembling increasingly more complex organic compounds (4,5). Thus, iron-sulfur clusters in
proteins may be the descendants of the earliest progenitors of life on Earth, and continue to serve
essential roles in modern organisms.
An iron-sulfur protein may contain one or more iron-sulfur clusters, which can contribute
to protein function, maintain structural integrity, or accomplish both. Known iron-sulfur clusters
are composed of non-heme iron and inorganic sulfide that vary in configuration. The most common
ones are the 2-iron, 2-sulfur ([2Fe-2S]) and 4-iron, 4-sulfur ([4Fe-4S]) clusters (Figure 1.1),
although more complex structures exist, such as the [8Fe-7S] cluster of nitrogenase in nitrogenfixing bacteria (6). Iron-sulfur clusters are often hosted within proteins by cysteine residues via
the sulfhydryl R-group of the cysteine(s) coordinating the iron atoms, although other amino acids,
such as histidine or aspartic acid, can also act as ligands (7,8).
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1.2 Iron-sulfur cluster biogenesis
Iron-sulfur cluster-containing proteins are ubiquitous in biological systems, but the
mechanism by which these clusters are assembled remains to be fully understood. Iron-sulfur
clusters are readily assembled in vitro with ferrous iron and sulfide in the presence of a reducing
agent (9). However, high levels of iron and sulfide in cells are toxic, as free iron can promote the
generation of free radicals (10) and sulfide has been shown to adversely affect multiple cellular
functions including oxidative phosphorylation (11). Thus, biological systems have adapted
complex systems to efficiently assemble iron-sulfur clusters in proteins while maintaining
physiologically tolerable levels of free iron and sulfide. Like the iron-sulfur proteins themselves,
iron-sulfur biogenesis is also highly conserved in organisms (2).
There are three major iron-sulfur cluster assembly systems present in bacteria: ISC, SUF
and NIF (1). The ISC system is encoded by the iscRSUA-hscBA-fdx-IscX gene cluster which
represents the housekeeping iron-sulfur cluster assembly activity (12), and is highly conserved
from bacteria to humans (13). The SUF system, encoded by the sufABCDSE gene cluster (14), is
activated in response to conditions of oxidative stress or iron starvation (15). The SUF system has
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been found in bacteria, archaea, and plants (15), and a SUF fusion protein was also recently
identified in a eukaryotic parasite (16). The NIF system, originally discovered in Azotobacter
vinelandii (17,18), is encoded by the nifUSVWZM gene cluster and is dedicated to assembling the
iron-sulfur clusters of nitrogenase (19).
The iscRSUA-hscBA-fdx-IscX gene cluster in E. coli encodes eight proteins (Figure 1.2)
(12). The first protein encoded in the ISC gene cluster is IscR, a [2Fe-2S] protein and a
transcriptional repressor that regulates the ISC gene cluster (20). The [2Fe-2S] clusters will only
accumulate on IscR when iron-sulfur clusters in the cell are abundant; thus, the repression activity
of IscR prevents wasteful iron-sulfur cluster assembly. During oxidative stress or iron starvation
conditions, IscR lacking an iron-sulfur cluster is generated, which de-represses the ISC operon and
leads to an increase in iron-sulfur cluster assembly (21). In tandem, IscR lacking its iron-sulfur
cluster will activate the SUF system to stimulate iron-sulfur cluster production in conditions of
iron starvation or oxidative stress (22). Thus, IscR is a major regulator of iron-sulfur cluster
assembly in response to iron availability or oxidative stress.
IscS, IscU, and IscA comprise the basal iron-sulfur cluster assembly machinery of the ISC
system. IscS is a cysteine desulfurase that extracts sulfide (S2-) from L-cysteine using a pyridoxal
phosphate (PLP) cofactor, and generates a persulfide intermediate harbored in IscS which provides
the sulfur atom for iron-sulfur cluster assembly (23). IscU is a scaffold protein upon which nascent
iron-sulfur clusters are built (24). IscS first forms a complex with IscU and the sulfur atom from
IscS is transferred to IscU (25). Iron atoms may be provided for cluster assembly on IscU by the
proposed iron donor IscA (26), and donation of electrons leads to the assembly of [2Fe-2S] and
[4Fe-4S] clusters on IscU from the delivered sulfide and iron (27).
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The [Fe-S]-loaded IscU then directly transfers its iron-sulfur clusters to recipient proteins,
and the transfer can be stimulated by the co-chaperones HscB and HscA via a concerted sequence
of protein interactions (28,29). IscU exists in a disordered (D) state when it does not have an ironsulfur cluster, but adopts a structured (S) state upon acquiring an iron-sulfur cluster. D-IscU is
preferentially bound by IscS for the iron-sulfur cluster assembly, but IscS has weaker affinity for
the [Fe-S]-loaded S-IscU. Subsequently, S-IscU is competed off of IscS by HscB which delivers
it to its ATPase co-chaperone, HscA. Hydrolysis of ATP in HscA then facilitates the iron-sulfur
cluster release from IscU (28). Thus, the HscB / HscA co-chaperones stimulate both the
dismantling of [Fe-S]-loaded IscU from IscS and the iron-sulfur cluster release from IscU in an
ATP-dependent mechanism, increasing the rate of iron-sulfur cluster delivery to recipient proteins
(29).
Ferredoxin (Fdx) is encoded downstream of the HscB / HscA co-chaperones and contains
a stable [2Fe-2S] cluster. Although its function is not fully understood, Fdx is predicted to act as
the electron donor for iron-sulfur cluster assembly on IscU, based on evidence of its association
with IscS (30,31) and its ability to reductively couple two [2Fe-2S] clusters to form a [4Fe-4S]
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cluster on IscU (32). Recently, it was demonstrated that ferredoxin-NADP+ reductase can facilitate
electron donation in iron-sulfur cluster assembly by providing electrons to ferredoxin (33).
The last protein encoded in the ISC gene cluster is IscX, a small acidic protein recently
proposed to donate iron for the iron-sulfur cluster assembly process (34). However, IscX has a
very weak binding affinity for iron (35), and an iscX deletion has only a mild phenotypic effect on
E. coli cells. On the other hand, IscX was shown to interact with both IscS and IscU (34),
suggesting that IscX may have functions in the iron-sulfur cluster assembly process that are
unrelated to iron delivery.
While much of the ISC system has been described, the protein responsible for delivering
iron in this process remains unestablished. Before the reports for IscX, the human frataxin and its
E. coli homolog CyaY were initially posited to be possible iron chaperones (36,37). However, like
IscX, frataxin and CyaY do not bind significant amounts of iron under physiological reducing
conditions (26,38). Furthermore, deletion of cyaY in E. coli has no change in phenotype (39).
Another candidate for iron delivery to the ISC system is IscA. When it was first characterized,
IscA was hypothesized to be a scaffold protein similar to IscU, as both proteins share a threecysteine ligand arrangement capable of binding an iron-sulfur cluster (40,41). It was reported that
iron-sulfur clusters can be readily assembled on IscA and its paralogs SufA and NifA in vitro
(42,43), and [Fe-S]-bound IscA can transfer its cluster to recipient proteins (44). However, the
severe growth deficiency of an iscU deletion in E. coli cannot be suppressed by overexpressing
IscA (42), and an iscA deletion in E. coli has no change in phenotype (42). Thus, IscA may not act
as a scaffold protein in parallel with IscU, and [Fe-S]-bound IscA does not appear to have an
essential role in iron-sulfur cluster assembly.
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Unlike IscU, the striking feature of IscA is its strong affinity for iron in vitro (45,46) and
in vivo (26), which supports the hypothesis that IscA could act as an iron donor for the iron-sulfur
cluster assembly process. Iron binding in IscA is conserved in bacterial (41,47), yeast (48), and
human homologs (49), as well as its SUF system paralog SufA (42). Furthermore, iron bound to
IscA and SufA can provide iron for iron-sulfur cluster assembly on IscU (26) and iron-sulfur
proteins such as dehydratases (50). IscA can also acquire iron from the iron storage protein ferritin
(51), and the acquired iron can be readily extracted from IscA by L-cysteine (45), suggesting that
IscA may efficiently procure and deliver iron for iron-sulfur cluster assembly. The proposed
function of IscA as an iron donor has been summarized in the “USA” model of iron-sulfur cluster
assembly (52) (Figure 1.3).
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IscA and SufA are complementary in function and together they are essential for E. coli
cells in vivo, as simultaneous deletion of both iscA and sufA results in a null growth phenotype in
minimal media (50). Furthermore, the iscA-/sufA- E. coli cells fail to assemble [4Fe-4S] clusters in
proteins when grown in rich media (50). Iron binding in IscA is also inhibited in vivo by copper
(Cu2+), which likely competes for the same binding site in IscA as iron, and thus impairs the
assembly of [4Fe-4S] clusters (53). Copper binding in IscA to prevent iron-sulfur cluster assembly
has been proposed to contribute to copper toxicity in bacteria. Taken together, IscA appears to be
a major iron donor for iron-sulfur cluster biogenesis.
In particular, the ISC system has been extensively studied for its implications in human
disease. One of the earliest links of iron-sulfur assembly to disease was found in Friedreich’s
ataxia, caused by an inherited mutation in the frataxin gene leading to reduced expression of the
protein (54). Although its function is not clear, frataxin contributes to efficient iron-sulfur cluster
assembly in the mitochondria (55), and the protein localizes to the mitochondrion and weakly
binds iron (56). More recently, an inherited mutation in the gene encoding human IscU was
associated with mitochondrial myopathy, in which individuals develop severe fatigue after light
physical exertion (57). There have also been reports that mutation in the human cysteine
desulfurase, NFS1, causes infant fatality due to the deficiency of iron-sulfur cluster assembly in
complex II and complex III in mitochondria (58). Mutations in other predicted iron-sulfur cluster
biogenesis proteins are attributed to mitochondrial dysfunctions affecting the heart and central
nervous system (58). Thus, the pathology of many debilitating diseases may be clarified by further
investigation of the ISC system mechanics and its acquisition of iron and sulfur.
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1.3 Iron-sulfur proteins and oxidative stress
The primary function of most iron-sulfur clusters is to transfer electrons. The reversible
conversion of a ferric (Fe3+) iron to a ferrous (Fe2+) iron in the cluster allows it to participate in a
wide array of redox reactions. This capability was first observed in ferredoxins in 1962, when they
were discovered to transfer electrons during nitrogen fixation in an anaerobic bacterium (59) and
photosynthesis in spinach (60). The ferredoxins are a group of redox active proteins with [2Fe2S], [3Fe-4S] and [4Fe-4S] configurations functioning in multiple redox states in cells (61). Aside
from nitrogen fixation and photosynthesis, electron transfer carried out by iron-sulfur proteins
occurs in physiological processes including respiration and other metabolic pathways (62).
Ironically, while many iron-sulfur clusters in proteins participate in electron transfer
reactions, they are also susceptible to damage from free radicals such as radical oxygen species
(ROS). The iron centers in the iron-sulfur clusters are readily oxidized by ROS, which could cause
the iron to be released from the clusters (63). As iron-sulfur proteins often require an intact ironsulfur cluster for their function, destruction of the cluster could lead to inactivation of these
proteins (64), leaving specific biological pathways compromised. Furthermore, free iron released
from the damaged iron-sulfur clusters may promote the generation of hydroxyl radicals via the
Fenton reaction (10), which further exacerbates cellular oxidative stress (Figure 1.4). Owing to the
sensitivity of iron-sulfur clusters to ROS, biological systems have also utilized them as redox
sensors in response to oxidative stress (65).
A prevalent ROS species in cells is the superoxide anion (·O2-). Superoxide is typically
generated as a byproduct from enzymes such as xanthine oxidase and NAD(P)H oxidase (66), and
from electron leakage to oxygen during oxidative phosphorylation, particularly from complex I
(67) and complex III (66) in mitochondria. Superoxide from these sources can be removed from
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the cell by superoxide dismutase (SOD), which will convert superoxide into hydrogen peroxide
and molecular oxygen (68). However, extracellular factors including redox cycling agents (69) and
ultraviolet radiation (70) can promote the production of superoxide and other ROS in cells to
enhance oxidative stress. Cells will mobilize expression of multiple genes to alleviate oxidative
stress and to repair the damage inflicted by oxidative stress.
In E. coli, excessive superoxide in is sensed by the redox transcription factor SoxR (71).
SoxR exists as a dimer with a [2Fe-2S] cluster in each protein subunit (72). Under normal
conditions, the SoxR [2Fe-2S] clusters are in the reduced state and SoxR has no activity (73).
However, superoxide will oxidize the [2Fe-2S] clusters in SoxR, which induces a conformational
change; absence of the [2Fe-2S] cluster produces a similar result (74). The activated SoxR will
then activate the transcription of the gene encoding SoxS, which in turn activates the soxRS regulon
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for the transcription of over 30 genes utilized in the oxidative stress response (75). Oxidation of
the SoxR [2Fe-2S] cluster is reversible in vivo, as the dimer with reduced SoxR [2Fe-2S] clusters
is quickly regenerated after excess superoxide is removed from E. coli cells (76).
The [2Fe-2S] cluster in SoxR is one example of many iron-sulfur clusters in proteins that
sense oxidative stress. Another example is DinG, an E. coli DNA damage-inducible helicase that
is activated when its [4Fe-4S] cluster is oxidized to facilitate DNA repair in oxidative stress
conditions (77). The human Regulator of telomere length (Rtel1) (78) is a DNA helicase predicted
to contain an iron-sulfur cluster, and may also have a redox-dependent helicase activity similar to
DinG. The human outer mitochondrial membrane protein mitoNEET is thought to function in
mitochondrial metabolism and contains a [2Fe-2S] cluster (79) that may undergo redox transitions
to sense the intracellular redox state. Rtel1 and mitoNEET will be discussed further in Section 1.5.

1.4 Iron-sulfur proteins and nitric oxide cytotoxicity
Iron-sulfur proteins are not only sensitive to reactive oxygen species, but also to nitric oxide
(NO). NO is a membrane-diffusible free radical that acts as a signaling molecule for many
biological processes (80). NO is canonically produced by NO synthases (NOS) through the
conversion of L-arginine to L-citrulline (81), but can also be generated as an intermediate by nitrite
reductases (82), through a side reaction of molybdoenzymes (83), or by the acidification of nitrite
(84). In humans, NO serves as a crucial signaling molecule for regulation of the nervous and
cardiovascular systems (80). Neuronal NOS (nNOS, or NOS-1) was originally identified in the
brain and serves as an important neurotransmitter (85) with implications in neurodegenerative
diseases (86). Endothelial NOS (eNOS, or NOS-3) was originally discovered in the endothelial
tissue, where it generates NO for vasodilation of blood vessels to promote blood flow (85). NO
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has thus been a promising therapy to protect against ischemia-reperfusion injury (87) or treat
pulmonary hypertension (88).
While NO is a crucial signaling molecule at nanomolar concentrations, it becomes
cytotoxic at micromolar concentrations (89). High concentrations of NO are generated in vivo by
inducible NO synthase (iNOS, or NOS-2), which is expressed in neutrophils and activated
macrophages during an immune response (89,90). This heightened production of NO can provide
a line of defense to kill both bacterial pathogens and tumor cells (89,91). Among the effects of
cellular damage, NO can irreversibly oxidize thiol groups on proteins (92) and react with
superoxide to form peroxynitrite (ONOO-), a potent free radical that causes DNA, lipid, and
protein oxidation (93).
In bacteria, the primary targets of NO cytotoxicity are the iron-sulfur proteins. Upon
exposure to NO, the iron-sulfur clusters form dinitrosyl-iron complexes (DNICs) (Figure 1.5),
composed of two NO molecules bound to a single iron atom (94). This modification process was
first seen in Clostridium botulinum treated with nitrite and ascorbate, which produced a EPR signal
at g = 2.04, characteristic of DNICs (95). Indeed, micromolar concentrations of NO inhibit E. coli
cell growth, which is concomitant with DNIC formation in the cells (96).
In bacteria, NO cytotoxicity is counteracted by cellular stress responses against NO. SoxR,
while principally serving as a sensor for superoxide, is activated via NO modification of its [2Fe2S] cluster (97). The DNIC-bound SoxR activates the oxidative stress response by the same
mechanism as the oxidized SoxR after exposure to ROS (74). Recently another [2Fe-2S] protein,
NsrR, was characterized as a novel redox sensor of NO (98). NsrR acts as a transcriptional
repressor. Upon NO modification of the [2Fe-2S] cluster, the activated NsrR dissociates from
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DNA (99). NsrR activation regulates the expression of over 60 genes in bacteria for the NO
response, including genes encoding NO reductases to detoxify intracellular NO (100).

Counteracting NO cytotoxicity not only requires removal of NO, but also an efficient
process to remove protein-bound DNICs and subsequently re-assemble new iron-sulfur clusters in
proteins. DNIC removal can be facilitated by L-cysteine, which results in the decomposition of
DNICs (96). Oxygen is required for this process in vitro and in vivo. (101). Specifically, the DNIC
is predicted to transfer from the protein to L-cysteine by thiol exchange, forming L-cysteine-bound
DNICs. The L-cysteine-bound DNICs are unstable in the presence of oxygen and readily
decompose, which is detectable by their breakdown to nitrite and ferrous iron (101). The ironsulfur cluster repair mechanism following extraction of DNICs remains unclear, but likely involves
the actions of iron-sulfur cluster assembly machinery (102,103), and a di-iron protein YtfE (104),
whose expression is regulated by NsrR (105,106). The ISC gene cluster would also be de-repressed
12

due to NO modification of the IscR [2Fe-2S] cluster and its dissociation from DNA, which may
promote iron-sulfur assembly to repair the NO-modified proteins. Subsequently, the NO-modified
IscR can also activate the SUF system to provide additional iron-sulfur cluster assembly activity
(22).

1.5 Key iron-sulfur proteins related to human health
As previously mentioned, several diseases are attributed to mutations in proteins involved
in iron-sulfur cluster biogenesis, such as frataxin (54), IscU (57), and NFS1 (58). In addition,
diseases have also been attributed to iron-sulfur proteins, including the increased succinate
dehydrogenase expression in cancer (107), inactivated aconitase in Parkinson’s disease (108), and
genomic instability due to mutations in DNA helicases (109). Discussed below are two examples
of iron-sulfur proteins related to human disease. The first example is Regulator of telomere length
(Rtel1), a predicted iron-sulfur protein and DNA helicase that maintains the integrity of telomeres
(78). The second example is MitoNEET, a small outer mitochondrial membrane [2Fe-2S] protein
implicated in mitochondrial metabolism and diabetes.
Regulator of telomere length (Rtel1) functions to prevent telomere shortening (78). The
shortening of telomeres is regarded as one of the primary contributors to aging (110), as loss of
DNA at telomeres can cause genomic instability and oxidative stress (111). Ironically, telomeres
are susceptible to loss of DNA at their ends (112). DNA is replicated semi-conservatively on a
leading and lagging strand of DNA, the latter of which requires RNA primers to synthesize
Okazaki fragments. The end of telomeric DNA on the lagging strand, however, cannot receive a
final Okazaki fragment because it requires a primer to precede it for DNA polymerase binding.
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Thus, replication at telomere ends leaves a 3’ overhang of single-stranded DNA that is vulnerable
to degradation by nucleases as a result of the “end replication problem” (113,114).
Fortunately, the vulnerable telomeric DNA resulting from the end replication problem can
be repaired and / or protected. Human telomeric DNA is composed of TTAGGG repeats, and
additional nucleotides can be added on the 3’ single-stranded DNA by telomerase, a reverse
transcriptase with a complementary RNA template of CCCAAUCCC contained within the protein
structure (115). Additionally, the repetitive telomere DNA sequence can allow the 3’ overhang to
invade the upstream double-stranded DNA to form a triple-stranded displacement loop (D-loop).
The D-loop results in the enclosure of a T-loop at the telomere (116) that can be further stabilized
by a complex of proteins known collectively as shelterin (117). The T-loop and shelterin protect
the 3’ end of telomeric DNA from nucleolytic degradation, but this protective measure must be
disassembled for access by telomerase or for another cycle of replication. To facilitate this process,
the triple-stranded D-loop is unwound by the helicase Rtel1, thereby dismantling the T-loop
structure for DNA processing to commence.
Owing to its responsibility in maintaining telomere length and protection, Rtel1 helicase
activity must be tightly regulated. Studies in mice have demonstrated that deficiency in Rtel1
activity allows persisting D-loops to be detected by resolvases, which will process the D-loop to
form telomeric DNA circles (T-circles) and loss of DNA at the telomeric end (118). In contrast,
overexpression of Rtel1 in mice leads to the excessive dismantling of T-loops, exposing the singlestranded telomeric ends and increasing telomere fragility (118) (Figure 1.6).
Since its discovery, there have been many developments associating dysfunctional Rtel1
with disease. Rtel1-mediated telomere maintenance in humans was first identified when mutations
in Rtel1 were linked to Hoyeraal-Hreidarsson syndrome (HHS), a severe form of dyskeratosis
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congenita characterized by shortened telomeres among other developmental and immune
symptoms (119,120). Mutations in Rtel1 have been associated with idiopathic pulmonary fibrosis

(121), gliomas (122), and pediatric brain tumors (123), while upregulation of Rtel1 is seen in
several other cancers (124). In the light of these findings, further biochemical characterization of
Rtel1 is a necessity.
Rtel1 is a member of the superfamily II (SF2) DNA helicases which contain a conserved
DEAD / DEAH box (125). Human Rtel1 homologs include xeroderma pigmentosum factor D
(XPD) (126), Fanconi’s anemia complementation group J / BRCA1-associated C-terminal helicase
(FANCJ / BACH1) (127), and Warsaw breakage syndrome helicase ChlR1 (128). All of these
proteins, including Rtel1, contain an iron-sulfur cluster binding motif (126,129). E. coli DNA
helicase DinG, a homolog of XPD and BACH1, also contains a DEAD box and a redox active
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[4Fe-4S] cluster (130). DinG is activated by oxidative stress conditions, as it becomes active to
unwind DNA when its iron-sulfur cluster is oxidized; when the cluster is re-reduced, the helicase
is inactivated (77). Thus, the presence of an iron-sulfur cluster in Rtel1 may implicate a possible
redox-mediated regulation of its helicase activity that could link oxidative stress to telomere
maintenance.
The outer mitochondrial membrane protein mitoNEET has been of great interest in recent
years due to its possible association with type II diabetes, which has been designated an epidemic
due to ever-increasing incidences of the disease. By the year 2050, a projected one in three
Americans will be diabetic (131). Type II diabetes is characterized by a resistance to insulin which
leads to dysfunctional metabolism and obesity. Due to the metabolic alterations that are a hallmark
of the disease, particularly hyperglycemia, diabetes has also been linked to the progression of
cancer growth (132). Furthermore, diabetes exacerbates conditions within cardiovascular (133)
and neurodegenerative diseases (134). Since the 1990s, a prevalent class of drugs administered to
combat diabetes symptoms is the thiazolidinediones (TZDs) (135), which can improve insulin
sensitivity (136). One member of this class, pioglitazone (Figure 1.7), has been prescribed
worldwide for type II diabetes treatment after exhibiting improvements to both insulin sensitivity
(137) and control of glucose metabolism (138,139). Pioglitazone treatment has also been shown
to alleviate metabolic syndrome (140) and dementia brought on by diabetes symptoms (141).
The well-established binding target of pioglitazone is the peroxisome proliferator-activated
receptor γ (PPARγ) (136), a nuclear receptor primarily expressed in differentiating adipocytes
(142). PPARγ is activated upon binding to various fatty acid metabolites, making it a global lipid
sensor (143). Activated PPARγ regulates genes involved in insulin sensitivity and the homeostasis
of glucose and fatty acids (144), all of which are affected systems in diabetes. TZDs act as strong
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activators of PPARγ, which subsequently drives the secretion of insulin sensitizers from
adipocytes and thus produces the TZD-mediated antidiabetic response (145). Unfortunately, the
strength of TZDs in activating PPARγ is also predicted to be the cause of the severe side effects,
including liver damage (146), heart failure (147), and possibly bladder cancer (148).

Furthermore, some effects seen from TZDs originated from mitochondria and were
unrelated to the activation of PPARγ (149). In 2004, tritium-labeled pioglitazone detected
mitoNEET as an additional TZD binding target (150), and upon further characterization
mitoNEET was found to possess a [2Fe-2S] cluster (79). Due to its presence in mitochondria and
its increased expression in differentiating adipocytes, mitoNEET is speculated to play a role in
both lipid metabolism and insulin sensitivity (151). The binding of pioglitazone to mitoNEET
suggests that some antidiabetic effects observed from TZDs may be a direct result of altering
mitoNEET function. However, the exact function of mitoNEET in vivo remains unclear.
Genetic studies have suggested that mitoNEET is critical in regulating iron homeostasis
(151,152) and energy metabolism (150,151,153). Decreased levels of mitoNEET in mouse
adipocytes led to an increased uptake of iron, resulting in enhanced oxidative phosphorylation. As
a consequence, the increased metabolism attenuated weight gain in these mice when fed a high-fat
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diet (153). In contrast, mitoNEET enrichment in adipocyte mitochondria inhibited iron import,
which led to decreased oxidative phosphorylation, lipid accumulation in adipocytes, and obesity
(151). Thus, although its function remains to be determined, the mitoNEET may be involved in
regulating mitochondrial metabolism.
MitoNEET resides on the outer mitochondrial membrane as a dimer, and hosts the [2Fe2S] cluster via a ligand arrangement of three cysteine and one histidine residues (153,154). Due to
this unique ligand arrangement the cluster is particularly labile, with its stability influenced by pH
(155), inter-domain interactions (156,157) and the hydrogen bond network (158), as well as
binding of NADP+ or NADPH (155,159), intracellular zinc (160), resveratrol-3-sulfate (161), and
pioglitazone (162). Modulation of the [2Fe-2S] cluster by these factors led to the initial hypothesis
of mitoNEET as an iron-sulfur cluster transfer protein. Such a hypothesis was exciting, as it
implied a novel pathway for mitochondrial iron-sulfur clusters to reach cytosolic proteins. Indeed,
mitoNEET is capable of transferring its [2Fe-2S] cluster to apo-ferredoxin (159,163), and this
transfer activity can be inhibited by pioglitazone (163) or NADPH binding (159). It was also
demonstrated that mitoNEET can donate its [2Fe-2S] cluster for the repair of the [4Fe-4S] cluster
on iron regulatory protein 1 (IRP-1) to regenerate its active aconitase form (152). This suggested
that mitoNEET contributes to iron homeostasis, which supported the mouse genetic studies (151).
However, all of these transfer processes occur only when the mitoNEET [2Fe-2S] clusters are
oxidized. Furthermore, the rate of mitoNEET [2Fe-2S] cluster transfer is relatively slow, acting on
a time scale of hours (159,163). Thus, the conditions under which mitoNEET can transfer its [2Fe2S] cluster is greatly restricted to conditions that may not be deemed physiological.
Alternatively, mitoNEET may act as a redox sensor. The mitoNEET [2Fe-2S] cluster
possesses an unusually high redox midpoint potential (Em), suggesting that electron transfer to the
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cluster may be favorable in physiological conditions. The redox midpoint potential at pH 7.0 (Em7)
of the mitoNEET [2Fe-2S] cluster is ~0 millivolts (162,164). The intracellular environment is
normally in the reduced state (165), with the redox potential of eukaryotic cells estimated at
approximately -325 mV at pH 7.0 (166). Thus, mitoNEET [2Fe-2S] clusters may exist in the
reduced state in vivo, and the unique histidine ligand of the mitoNEET [2Fe-2S] cluster is
responsible for its unusually high redox midpoint potential (162). The redox characteristics of
mitoNEET are reminiscent of E. coli SoxR, a dimer with [2Fe-2S] clusters in the reduced state in
vivo that acts as a redox sensor of oxidative stress (73,97). In the context of diabetes, it is interesting
to speculate that mitoNEET acts as a redox sensor, as mitoNEET has numerous reported protein
binding partners (149,167-170) that could be regulated by this sensing activity. The binding of
pioglitazone causes a shift in the redox midpoint potential of the mitoNEET [2Fe-2S] cluster from
~0 to -100 mV (162), which may interfere with the redox transitions of the cluster and thus
modulate the signaling capabilities of mitoNEET.

1.6 Statement of research objectives
Iron-sulfur cluster biogenesis has been extensively studied due to its role in assembling
some of the most functionally diverse and widely conserved cofactors known. However, critical
features of the assembly process still remain unclear, including the source of iron for incorporation
into the clusters. IscA possesses a unique and strong iron binding affinity, and IscA can deliver
iron for the assembly process in vitro. The first aim of this work is to correlate the iron binding
ability in IscA with its function in cells, demonstrating that iron binding in IscA is essential to
iron-sulfur cluster assembly in vivo.
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The redox properties of iron-sulfur proteins allows them to serve in diverse cellular
processes, including electron transfer. Ironically, iron-sulfur clusters are a susceptible target of free
radicals such as nitric oxide (NO), which can destroy the clusters to generate dinitrosyl-iron
complexes and contribute to NO cytotoxicity. Although NO modification of iron-sulfur clusters is
well-characterized in vitro, it is unclear whether they contribute to DNICs observed in vivo, as
DNICs may also be produced by thiols or other proteins in combination with iron. The second aim
of this work is to identify the primary source of DNICs formed in E. coli cells under nitric oxide
stress.
Iron-sulfur proteins play essential roles in DNA synthesis and repair. Regulator of telomere
length (Rtel1) is a DNA helicase responsible for the maintenance of telomeric DNA, which is
vulnerable to nucleolytic degradation and shortening with each replication cycle. Rtel1 is a
member of the superfamily II helicases, all of which share an iron-sulfur cluster binding domain.
Rtel1 is implicated in a number of diseases, and although it has been investigated genetically, the
biochemical characterization of Rtel1 is still in its beginnings. The third aim of this work is to
confirm the presence of an iron-sulfur cluster in Rtel1 and characterize the role of the cluster as it
correlates to protein function.
The recently discovered [2Fe-2S] mitoNEET is a binding target of the broadly-prescribed
type II diabetes drug pioglitazone, and genetic studies have demonstrated its importance in
modulating iron homeostasis and metabolism in the mitochondria. The precise function of
mitoNEET, however, is unclear. Because of the unique redox properties of its [2Fe-2S] cluster,
mitoNEET may function as a redox sensor. The fourth aim of this work is to investigate
physiological redox transitions of mitoNEET [2Fe-2S] clusters, and how these transitions are
affected by the binding of the type II diabetes drug pioglitazone to mitoNEET.
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CHAPTER 2
IRON BINDING ACTIVITY IS ESSENTIAL FOR THE FUNCTION OF ISCA
IN IRON-SULFUR CLUSTER BIOGENESIS 1

2.1 Introduction
Throughout evolution, iron-sulfur clusters have become integral parts of diverse
physiological processes including photosynthesis, nitrogen fixation, sugar metabolism, cofactor
biogenesis, RNA modification and translation, DNA replication and repair, and gene expression
regulation (1-4). While iron-sulfur clusters can be assembled in proteins in vitro with ferrous iron
and sulphide, iron-sulfur cluster assembly in vivo requires a group of dedicated proteins that are
conserved from bacteria to humans (5). In Escherichia coli, the proteins encoded by a gene cluster
iscSUA-hscBA-fdx are primarily responsible for iron-sulfur cluster assembly under normal growth
conditions (5). The homologs of six of the proteins encoded by iscSUA-hscBA-fdx have been
identified in eukaryotic organisms (2). Among them, IscS is a cysteine desulfurase that catalyzes
desulfurization of L-cysteine (6-8) and provides sulfur for iron-sulfur cluster assembly in a scaffold
protein IscU (9-11). IscU in turn transfers the assembled clusters to target proteins (12,13). IscA
has been characterized as an alternative scaffold or intermediate carrier for iron-sulfur cluster
assembly (14,15). A comprehensive characterization of iron-sulfur cluster binding in an IscA
homolog

Nif

IscA from Azotobacter vinelandii has recently been reported (16). Two heat shock

cognate proteins, HscB and HscA, have specific interactions with IscU (17) and promote the
transfer of assembled clusters from IscU to target proteins in an ATP-dependent reaction (18,19).
1
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activity is essential for the function of IscA in iron-sulphur cluster biogenesis. Dalton transactions
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36

Ferredoxin, which contains a stable [2Fe-2S] cluster (20), is likely involved in the reductive
formation of a [4Fe-4S] cluster in scaffold protein IscU (21,22).
While the sulfur donor for iron-sulfur cluster assembly has been well established (6-8), the
iron donor(s) remains largely elusive. Frataxin, a mitochondrial protein that is linked to
neurodegenerative disease Friedreich's ataxia (23), has previously been characterized as a likely
iron donor for iron-sulfur cluster assembly (24,25). Deficiency of frataxin results in diminished
activity of iron-sulfur enzymes in yeast cells (26), and frataxin has physical interactions with ironsulfur cluster assembly protein IscU (27-29), the IscU / IscS complex (30,31), and with the ironsulfur enzyme aconitase in mitochondria (32). However, frataxin has a weak iron binding activity
with an iron binding constant of 4 to 55 μM (24,33,34). Such a low iron binding affinity may
preclude frataxin from binding any significant amounts of iron in mitochondria under normal
physiological conditions. Furthermore, deletion of frataxin homolog CyaY in E. coli does not
affect iron-sulfur cluster biogenesis (35), and frataxin-deficient yeast cells can be rescued by either
expressing ferritin (36) or vacuolar iron transporter CCC1 (37). In fact, scavenging H2O2 can
effectively restore iron-sulfur enzyme activities in a Drosophila model of Friedreich's ataxia (38).
Thus, the primary function of frataxin could be to maintain iron homeostasis under oxidative stress
(39,40) or to modulate overall iron-sulfur cluster assembly in cells (30,31). More recently, the
protein IscX, which lies downstream of the iscSUA-hscBA-fdx operon, has been proposed to be an
iron donor for iron-sulfur cluster assembly (41). Similar to frataxin, however, IscX has only a weak
binding affinity for iron (42,43). Furthermore, deletion of IscX in E. coli has only a mild effect in
iron-sulfur cluster assembly (44), suggesting that it may have other functions in the assembly
process unrelated to iron delivery.
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In previous studies, we reported that unlike other iron-sulfur cluster assembly scaffold
proteins such as IscU, IscA has a strong iron binding activity with an apparent iron association
constant of 1.0 x 1019 M-1 (45-49). A similar strong iron binding activity has been observed for the
IscA homolog from humans (50), yeast cells (51), and A. vinelandii NifIscA (52). In this study, we
present new evidence showing that among the primary iron-sulfur cluster assembly proteins, IscA
is unique in binding iron, and that the tightly-bound ferric iron in IscA can be readily extruded by
L-cysteine, followed by reduction to ferrous iron for iron-sulfur cluster assembly. Site-directed
mutagenesis studies show that the iron-binding activity is crucial for the physiological function of
IscA in iron-sulfur cluster biogenesis.

2.2 Materials and Methods
Protein preparation
The iron-sulfur cluster assembly proteins IscS, IscU, IscA, HscB, and HscA from E. coli
were prepared as described previously (47). The IscA mutant in which tyrosine 40 was substituted
with phenylalanine (Y40F) was constructed using the site-directed mutagenesis kit (Stratagene).
The mutation of gene iscA in the cloned plasmid was confirmed by direct sequencing. Human
frataxin was subcloned from plasmid pETHF2(53) to expression plasmid pET28b+ and prepared
as described in (50). The E. coli frataxin homolog CyaY was prepared as described in (48). The
protein concentration was determined from the absorption peak at 260 nm or 280 nm using the
previously-published extinction coefficient for each protein.
In vitro iron binding and iron-sulfur cluster assembly in IscA
For the iron binding experiments, each of purified iron-sulfur cluster assembly proteins (50
μM in monomer) was incubated with Fe(NH4)2(SO4)2 (50 μM) and sodium citrate (5 mM) in buffer
containing NaCl (200 mM), and Tris (20 mM, pH 8.0) in the presence of dithiothreitol (2 mM) at
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room temperature for 20 minutes, followed by passage through a HiTrap desalting column. Total
iron content in re-purified protein samples were determined using an iron indicator FerroZine as
described in (54). For iron-sulfur cluster assembly, purified IscA was incubated with IscS (0.5
μM), Tris (20 mM, pH 8.0), NaCl (200 mM), Fe(NH4)2(SO4)2 (50 μM), and dithiothreitol (2 mM)
at 37°C for 5 minutes under anaerobic conditions. L-cysteine (1 mM) was then added to initiate
the iron-sulfur cluster assembly reaction. The amount of iron-sulfur clusters assembled in protein
was monitored in a Beckman DU-640 UV-visible spectrophotometer.
EPR measurements
EPR (electron paramagnetic resonance) spectra were recorded at X-band on a Bruker ESR300 EPR spectrometer using an Oxford Instruments ESR-9 flow cryostat. The routine EPR
conditions were: microwave frequency, 9.45 GHz; microwave power, 10 mW; modulation
frequency, 100 kHz; modulation amplitude, 2.0 mT; temperature, 10 K; receive gain, 1.0 x 105.
In vivo activity assay of the IscA Y40F mutant
For the in vivo activity of the IscA Y40F mutant, the gene encoding Y40F was cloned into
a plasmid pBAD (Invitrogen). The constructed plasmid pBAD/Y40F was introduced into an E.
coli mutant in which gene iscA and its paralog sufA were in-frame deleted (55). The E. coli iscA/sufA-double mutant was viable in rich LB medium, but had a null-growth phenotype in M9
minimal medium under aerobic conditions (55). The E. coli iscA-/sufA- double mutant strain
containing pBAD/iscA and pBAD served as a positive and negative control, respectively.

2.3 Results
IscA has a unique iron binding activity among the iron-sulfur cluster assembly proteins
To explore the iron binding activity of the primary iron-sulfur cluster assembly proteins
encoded by the gene cluster iscRSUA-hscBA-fdx-iscX from E. coli (5), we expressed these proteins
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in wildtype E. coli cells grown in LB medium. Each protein was purified to a single band on the
SDS-PAGE gel. IscX iron binding was reported previously (42,43), and because IscR and
ferredoxin contain [2Fe-2S] clusters (20, 66), these proteins were not included for the iron binding
analysis. Among the other assayed iron-sulfur cluster assembly proteins encoded by iscRSUAhscBA-fdx-iscX, only purified IscA contained 0.09 ± 0.02 iron atoms per IscA dimer (Figure 2.1
A). No acid-labile sulfur was detectable in purified IscA, indicating that purified IscA did not
contain any significant amounts of iron-sulfur clusters.

The iron binding activity of purified iron-sulfur cluster assembly proteins was also
analyzed in vitro. Each purified protein was incubated with freshly-prepared ferrous iron in the
presence of dithiothreitol under aerobic conditions, followed by re-purification of the protein.
Figure 2.1 B shows that while the iron content in IscA increased to 1.05 ± 0.10 iron atoms per IscA
dimer after incubation with an equivalent amount of ferrous iron (relative to protein monomer),
40

the iron content in other proteins was less than 0.1 iron atoms per protein dimer, demonstrating
that IscA has a unique iron binding activity.
Until recently, the only other candidate proposed for the iron donor to iron-sulfur cluster
assembly in scaffold protein IscU was frataxin and its bacterial homolog CyaY (24,25). To explore
the iron binding activity of frataxin / CyaY in vitro under the same experimental conditions,
purified E. coli CyaY and human frataxin were incubated with an equivalent amount of ferrous
iron in the presence of dithiothreitol. Very little or no iron binding is found in re-purified CyaY
and human frataxin (data not shown), suggesting that unlike IscA from E. coli (45) and humans
(50), frataxin / CyaY has a very weak iron binding activity in the presence of dithiothreitol.
The ferric iron in IscA is extruded by L-cysteine, followed by reduction to ferrous iron
To access the iron in IscA for iron-sulfur cluster biogenesis, the iron stored in the protein
must be quickly released when there is such a demand. Previously, we reported that L-cysteine,
but not other related biological thiols including N-acetyl-L-cysteine or reduced glutathione, can
efficiently release iron from the iron-bound IscA (56). However, the mechanism underlying the Lcysteine-mediated iron release from IscA was not clear.
Iron-bound IscA has an unusual EPR signal at g = 4.3 and 6.0 (45). The signal is completely
eliminated upon removal of iron from the protein, and is fully restored after reconstitution with
iron, indicating that the EPR signal represents iron binding in IscA (45). Interestingly, a similar
EPR signal was previously reported for the S = 3/2, reduced [4Fe-4S] cluster in proteins such as
nitrogenase (57) and 2-hydroxyglutaryl-CoA dehydratase (58). While further biophysical studies
will be important to determine the spin state of the iron center in E. coli IscA, recent optical and
magnetic spectroscopic characterization of NifIscA, an IscA homolog from A. vinelandii, provided
comprehensive and convincing evidence for the assignment of the iron site in

41

Nif

IscA to a ferric

iron in an unusual rhombic spin S = 3/2 state (52). The EPR spectra of the iron-bound NifIscA from
A. vinelandii (52) and the iron-bound IscA from E. coli (45) are essentially the same. Furthermore,
the iron center in both E. coli IscA and NifIscA is redox active, as the EPR signal at g = 4.3 and 6.0
disappears when the iron center in IscA is reduced by sodium dithionite (45,52). To follow the
process of the L-cysteine-mediated iron release from IscA, we used EPR to monitor the redox state
of the iron center in IscA when the iron-bound IscA was incubated with L-cysteine under aerobic
conditions. At different time points, aliquots were taken from the incubation solution after addition
of L-cysteine for EPR measurements.
Figure 2.2 shows that upon addition of L-cysteine, the EPR signal at g = 4.3 and 6.0 of the
iron-bound IscA is quickly replaced with a new EPR signal at g = 4.3, representing “free” ferric
iron in solution (59). After further incubation (over 20 minutes), the newly-formed EPR signal at
g = 4.3 is gradually decreased, indicating that the “free” ferric iron is reduced to the EPR-silent
ferrous iron. As a control, incubation of the iron-bound IscA with N-acetyl-L-cysteine or reduced
glutathione does not affect the EPR signal at g = 4.3 and 6.0 of the iron-bound IscA (data not
shown). On the other hand, D-cysteine has the same activity as L-cysteine in releasing iron from
IscA (56), suggesting that the redox property, but not stereochemistry, of L-cysteine is responsible
for the iron release from IscA.
The transition of the EPR signal of the iron-bound IscA from g = 4.3 and 6.0 to g = 4.3
upon addition of L-cysteine indicates that the L-cysteine-mediated iron release from IscA may
have two distinctive steps. In the first step, L-cysteine extrudes ferric iron from IscA via ligand
exchange to form the L-cys-Fe3+-IscA and / or the L-cys-Fe3+ complex which contributes to the
observed EPR signal at g = 4.3 (Figure 2.2). In the second step, the L-cys-Fe3+-IscA and / or L-
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cys-Fe3+ complex is reduced by L-cysteine to the EPR-silent ferrous iron, which will be accessible
for iron-sulfur cluster biogenesis (47).

Mutation at residue tyrosine 40 to phenylalanine diminishes the iron binding activity of IscA
From the crystal structure, E. coli IscA is a homodimer with the three conserved cysteine
residues (Cys 35, Cys 99 and Cys 101) projected to form a “cysteine pocket” between two
monomers (60,61). Mutation of any of the three conserved cysteine residues to serine produced
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IscA mutant proteins that have a diminished iron binding activity (62) and are inactive in E. coli
cells (55). However, because the cysteine residues may accommodate either a mononuclear iron
or iron-sulfur cluster in IscA, mutation of cysteine residues would have affected both the iron and
iron-sulfur cluster binding in the protein.
Among the amino acid residues that are in the vicinity of the putative iron binding site in
IscA dimer, tyrosine 40 is highly conserved and located in the interface between two IscA
monomers (Figure 2.3). Unlike other nearby conserved residues that form a hydrophobic packing
between IscA monomers (60), the hydroxyl group of tyrosine 40 may act as a possible oxygenic
ligand for iron binding in IscA dimer (52).

To explore the role of tyrosine 40 in the iron binding and iron-sulfur cluster binding of
IscA, we constructed an IscA mutant in which tyrosine 40 was substituted with phenylalanine
(Y40F). The IscA mutant Y40F protein was purified and incubated with increasing concentrations
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of ferrous iron, followed by re-purification of the protein. Figure 2.4 shows that unlike wildtype
IscA, the absorption peak at 315 nm of the iron binding in IscA mutant Y40F is only slightly
increased after incubation with ferrous iron in the presence of dithiothreitol. The iron content

analyses revealed that after incubation with two-fold excess of iron per protein dimer, the ratio of
iron to the wildtype IscA dimer is 1.05 ± 0.10, while the ratio of iron to the IscA mutant Y40F
dimer is less than 0.15. The wildtype IscA and Y40F mutant proteins after reconstitution with a
two-fold excess of iron were re-purified, concentrated, and subjected to EPR measurements. While
wildtype IscA has a typical EPR spectrum of the iron-bound protein with g = 4.3 and 6.0, IscA
mutant Y40F only has a small EPR signal at g = 4.3 region (data not shown). In the light of recent
publication on the iron binding property of

Nif

IscA (52), it would be interesting to determine
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whether tyrosine 40 actually provides the oxygenic ligand for the iron binding in IscA. Regardless,
the results shown in Figure 2.4 clearly demonstrate that mutation of tyrosine 40 severely
diminishes the iron binding activity of E. coli IscA in vitro.

Next, we explored the iron-sulfur cluster binding activity of the wildtype IscA and IscA
mutant Y40F. Purified IscA and IscA mutant Y40F proteins were incubated with ferrous iron, Lcysteine, and a catalytic amount of IscS in the presence of dithiothreitol under anaerobic
conditions. After 20 minutes incubation, the iron-sulfur cluster assembly in IscA was analyzed.
Figure 2.5 shows that like wildtype IscA, the Y40F mutant retains iron-sulfur cluster binding
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activity, suggesting that mutation of tyrosine 40 does not significantly affect iron-sulfur cluster
assembly in IscA in vitro.
IscA mutant Y40F is inactive in E. coli cells
E. coli has at least two IscA paralogs: ErpA and SufA. ErpA, which maps at a distance
from any iron-sulfur cluster assembly-related genes, has been characterized as a dedicated scaffold
for maturation of several iron-sulfur enzymes (63-65) and transcription factors (66). SufA, on the
other hand, is a member of second iron-sulfur cluster assembly gene cluster sufABCDSE in E. coli
(67). Purified SufA, like IscA, has a strong iron binding activity and provides iron for iron-sulfur
cluster assembly in IscU in vitro (55). While deletion of IscA or SufA in E. coli cells only has a
mild effect on cell growth, deletion of both IscA and SufA results in a null-growth phenotype in
M9 minimal medium under aerobic conditions (55,68). Re-introducing IscA or SufA restores the
cell growth of E. coli iscA-/sufA- double mutant (55,69), suggesting that IscA and SufA are
complementary to each other.
To determine the in vivo activity of the IscA mutant Y40F, a plasmid expressing Y40F was
introduced into the E. coli iscA-/sufA- double mutant cells. The cells were inoculated in M9
minimal medium and grown under aerobic conditions. Figure 2.6 shows that unlike wildtype IscA,
the Y40F mutant failed to restore the cell growth of the E. coli iscA-/sufA- double mutant in M9
minimal medium under aerobic conditions. Since the IscA mutant Y40F has a diminished iron
binding activity but retains the iron-sulfur cluster binding activity, we propose that iron binding
activity is essential for the physiological function of IscA in iron-sulfur cluster biogenesis, while
the possible iron-sulfur cluster binding activity may be dispensable.
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2.4 Discussion
Phylogenomic analyses revealed that IscA is highly conserved from prokaryotic to
eukaryotic organisms (70). In A. vinelandii, depletion of IscA produces a null-growth phenotype
in modified Burks minimal medium under elevated oxygen conditions (71). In E. coli, deletion of
IscA and its paralog SufA results in a mutant that fails to grow in M9 minimal medium under
aerobic conditions (55,68). In S. cerevisiae, depletion of IscA homologs leads to iron accumulation
in mitochondria and dependency on lysine and glutamate in media (72). In human Hela cells, RNAi
knockdown of IscA homolog results in decreased activities of iron-sulfur enzymes in both
mitochondria and cytosol (73). Evidently, IscA has a crucial role for iron-sulfur cluster biogenesis,
especially under aerobic conditions. However, the physiological function of IscA remains
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controversial. One hypothesis stated that IscA acts as an alternative scaffold protein or
intermediate carrier for iron-sulfur cluster biogenesis, as IscA is able to bind an iron-sulfur cluster
and transfer the cluster to target proteins (14-16). However, unlike other scaffold proteins such as
IscU (9), IscA has a strong iron binding activity with a maximum binding of one iron per IscA
dimer (45-49). Recent spectroscopic characterization of
Nif

Nif

IscA from A. vinelandii confirms that

IscA is able to bind one iron per dimer, and that the iron center in IscA is in an unusual

intermediate S = 3/2 spin state (52). The results presented in this study provide new evidence for
the hypothesis that IscA is a bona fide iron binding protein.
Among the primary iron-sulfur cluster assembly proteins encoded by the gene cluster
iscRSUA-hscBA-fdx-iscX (5) and the putative iron donor frataxin / CyaY (24,25), only IscA has a
strong binding activity for mononuclear iron in the presence of dithiothreitol. Furthermore, the
ferric iron center tightly bound in IscA can be readily extruded by L-cysteine, followed by
reduction to ferrous iron. Additional studies further reveal that mutation at tyrosine 40, a possible
oxygenic ligand for the iron binding in IscA (52), diminishes iron binding activity but retains ironsulfur cluster binding activity of IscA. Genetic complementation studies show that Y40F is
inactive in vivo, suggesting that the iron binding activity is essential for the physiological function
of IscA. Collectively, the results support the hypothesis that IscA may act as an iron donor for
iron-sulfur cluster biogenesis. Nevertheless, since IscA can also bind iron-sulfur clusters (14,15)
and transfer the assembled clusters to target proteins (16), the role of IscA as an alternative scaffold
protein cannot be excluded. Perhaps the iron binding in IscA could be the initial step for ironsulfur cluster assembly either in IscA, or in other scaffold proteins such as IscU (47). Evidently,
additional experiments are required to illustrate the role of IscA in iron-sulfur cluster biogenesis.
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It is worth pointing out that IscA / SufA is dispensable for cell growth of E. coli in M9
minimal medium under anaerobic conditions (49). Interestingly, most anaerobic organisms do not
contain an IscA homolog and almost all aerobic organisms contain at least one copy of IscA in
their genomes (70). It may be envisioned that under anaerobic conditions, intracellular “free” iron
is more readily available for iron-sulfur cluster biogenesis and IscA is unnecessary. In aerobic
organisms, however, functional IscA would be required to recruit intracellular iron and deliver
iron or iron-sulfur clusters for iron-sulfur cluster biogenesis under aerobic conditions.
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CHAPTER 3
IRON-SULFUR PROTEINS ARE THE MAJOR SOURCE OF PROTEIN-BOUND
DNICS FORMED IN E. COLI CELLS UNDER NITRIC OXIDE STRESS 2

3.1 Introduction
Nitric oxide (NO) is produced from L-arginine by NO synthases (1) or from nitrite by
chemical reduction (2) or nitrite reductases (3), and has diverse physiological functions. At low
concentrations (nM), NO acts as a signaling molecule for intercellular communication in neuronal
and cardiovascular systems (4). At high concentrations (µM), NO becomes a powerful weapon
that kills pathogenic bacteria and cancer cells (5). Among the cellular targets of NO cytotoxicity
are proteins that contain iron-sulfur clusters (6-14). Iron-sulfur proteins are involved in a broad
range of physiological processes, from energy metabolism to DNA synthesis and repair (15,16).
In vitro studies have shown that NO can directly react with iron-sulfur clusters (17,18) forming
protein-bound dinitrosyl-iron complexes (DNICs) (19-27). The NO-mediated formation of
protein-bound DNICs has also been observed in bacterium Clostridium botulinum where NO is
produced from nitrite reduction (28), in activated macrophages where NO is produced by inducible
NO synthase (29,30), in tumor cells co-cultured with activated macrophages (31), in post-operative
day-4 allografts (32), in the gastro-esophageal junction (11), and in cultured mammalian cells
treated with various NO donors (33-36). When Escherichia coli cells are exposed to pure NO gas
at concentrations (μM) that emulate pathophysiological production of NO (37,38), a large number
of iron-sulfur proteins are modified forming protein-bound DNICs (12), suggesting that iron-sulfur
proteins are one of primary targets of NO cytotoxicity (8,10,12).
2

This chapter previously appeared as: Landry, A. P., Duan, X., Huang, H., and Ding, H. (2011)
Iron-sulfur proteins are the major source of protein-bound dinitrosyl iron complexes formed in
Escherichia coli cells under nitric oxide stress. Free radical biology & medicine 50, 1582-1590.
Modified and reprinted with permission of Elsevier.
57

NO can also react with small molecule thiols and ferrous iron to form thiol-bound DNICs,
which have a similar electron paramagnetic resonance (EPR) signal at g = 2.04 as protein-bound
DNICs (39-41). However, the existence of small molecule thiol-bound DNICs has never been
demonstrated in any living cells (42,43), likely because small molecule thiol-bound DNICs are not
stable in aqueous solution (e.g. the half-life time of the cysteine-bound DNIC is less than 1 minute)
(27,44) or are quickly exported by the multidrug resistance-associated protein-1 (34). The only
stable glutathione-bound DNICs in cells are found to be associated with glutathione S-transferases,
a potential protection mechanism against excess NO (43). More recently, it has been postulated
that large molecular mass-bound DNICs, instead of small molecule thiol-bound DNICs, are
formed in cultured mammalian cells under NO stress (35,36). However, the identities of large
molecular mass-bound DNICs have not been defined (35,36).
In this study, we combine molecular genetics and biophysics approaches and demonstrate
that iron-sulfur proteins are the major source of large molecular mass-bound DNICs formed in E.
coli cells under NO stress. Expression of recombinant iron-sulfur proteins almost doubles the
amount of protein-bound DNICs formed in E. coli cells under NO stress. Deletion of the ironsulfur cluster assembly proteins IscA and SufA to block the [4Fe-4S] cluster assembly (45,46)
largely eliminates the NO-mediated formation of protein-bound DNICs in E. coli cells, suggesting
that iron-sulfur clusters, but not “free” iron, are mainly responsible for the NO-mediated formation
of protein-bound DNICs. Furthermore, depletion of the “chelatable iron pool” in the wildtype E.
coli cells effectively removes iron-sulfur clusters from proteins and concomitantly diminishes the
NO-mediated formation of protein-bound DNICs, suggesting that iron-sulfur clusters in proteins
constitute at least part of the “chelatable iron pool” in cells. The physiological relevance of the
NO-mediated modification of iron-sulfur proteins will be discussed.
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3.2 Materials and Methods
Gene cloning and protein purification
The genes encoding E. coli aconitase B (47), dihydroxyacid dehydratase (IlvD) (48), the
redox transcription factor SoxR (22), the heat shock cognate protein HscA (49), and the singlestranded DNA-binding protein SSB (50) were cloned into pET28b+ (Novagen) or pBAD
(Invitrogen) expression vectors as described previously (25). Cloned genes were confirmed by
direct sequencing (LSU Gene Lab). Recombinant proteins were expressed in E. coli strain
BL21(DE3), MC4100, or the iscA-/sufA- double mutant (45) cells, and the protein expression was
confirmed by SDS-PAGE analyses. The protein expression clones of E. coli ASKA library (51)
were also used for the expression of IlvD, SoxR, HscA, and SSB. All protein purification solutions
were purged with pure argon gas before use. Recombinant proteins were purified as described in
(25), and the purity of purified proteins was over 95% judging from SDS-PAGE analyses.
NO exposure of E. coli cells
Overnight E. coli cells containing protein expression plasmid were diluted 1:100 in freshly
prepared LB (Luria-Bertani) medium and incubated at 37oC with aeration (250 rpm) for 3 hours,
followed by protein induction with IPTG (100 μM) or arabinose (0.02%) for an additional 2 to 3
hours. For the iscA-/sufA- double mutant, the cells were grown for 8 hours before protein induction
with arabinose for an additional 4 hours (45). Both the wildtype and mutant cells were harvested
and re-suspended in M9 minimal medium to an O.D. at 600 nm of 4.0-6.0. Chloramphenicol (34
μg/mL) was added to the harvested E. coli cells to block new protein synthesis. Cells were then
purged with pure argon gas before being treated with the NO-releasing reagent diethylamine
NONOate (Cayman Chemical) at 37°C for 5 minutes. Diethylamine NONOate was dissolved in
buffer containing Tris (20 mM, pH 10.5), and the concentration of the NONOate was determined
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from the absorption peak at 250 nm using an extinction coefficient of 6.5 mM-1cm-1. Diethylamine
NONOate releases 1.5 moles of NO at a half-life time of 2 minutes at 37°C (pH 7.4). Released NO
was monitored using an NO electrode (World Precision Instruments). The Silastic tubing NO
delivery system (52) was also used for the NO exposure of E. coli cells as described previously
(12). Similar results were obtained when E. coli cells were exposed to NO using either
diethylamine NONOate or the Silastic tubing NO delivery system.
Depletion of the “chelatable iron pool” in E. coli cells
E. coli cells containing the protein expression plasmid or the vector only were diluted 1:100
in freshly prepared LB medium and incubated at 37°C with aeration (250 rpm) for 3 hours,
followed by protein induction with L-arabinose (0.03%) for additional 2 hours. Cells were
harvested and suspended in M9 minimal medium to O.D. = 8.0. The iron chelator 2,2’-dipydyl
was then added to the cells, and incubated at 37°C for various times. Cells were then washed once
with M9 minimal medium before being treated with NONOate at 37°C for 5 minutes. For the
measurements of “chelatable iron pool” content, the cells were passed through the French press
once, followed by centrifugation to remove cell debris. The amount of “chelatable intracellular
iron” in cells was measured from the absorption peak at 520 nm of the iron-dipyridyl complex
using an extinction coefficient of 5.2 mM-1cm-1 (53).
Aconitase activity assay
For the aconitase activity assay, an aliquot of freshly prepared cell extracts was transferred
to a pre-incubated solution containing Tris (90 mM, pH 8.0) and D,L-isocitrate (20 mM) at 25°C
as described in (25). The reaction was monitored at 240 nm using an extinction coefficient of 3.6
mM-1cm-1 for aconitate in a Beckman DU640 UV-visible spectrophotometer equipped with a
temperature controller.
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EPR measurements
The X-band EPR spectra were recorded using a Bruker model ESR-300 spectrometer
equipped with an Oxford Instruments 910 continuous flow cryostat. Routine EPR conditions were:
microwave frequency, 9.47 GHz; microwave power, 10.0 mW; modulation frequency, 100 kHz;
modulation amplitude, 1.2 mT; temperature, 25 K; receive gain, 1 x 105. A freshly prepared
glutathione-bound DNIC solution was used as a reference for quantification of protein-bound
DNICs (12).

3.3 Results
Recombinant iron-sulfur proteins are modified to form protein-bound DNICs in E. coli cells
under NO stress
When wildtype E. coli cells were exposed to NO using the NO releasing reagent
diethylamine NONOate, a unique EPR signal at g = 2.04 reflecting protein-bound DNICs (19-27)
appeared, as reported previously (12). However, when recombinant iron-sulfur protein aconitase
B (47) was expressed in the E. coli cells, the amount of protein-bound DNICs formed by the same
NO exposure was significantly increased (Figure 3.1 A). A titration of the NONOate concentration
revealed that the amount of protein-bound DNICs formed in E. coli cells with recombinant
aconitase B was about twice as much as that of the E. coli cells without recombinant protein when
the cells were exposed to 50 μM or more of NONOate (Figure 3.1 B).
To further explore the correlation between iron-sulfur proteins and the NO-mediated
formation of protein-bound DNICs, we expressed recombinant aconitase B in E. coli cells to
various levels, followed by NO exposure. As shown in Figure 3.2, when the expression level of
recombinant aconitase B was gradually increased (panel C), the amount of protein-bound DNICs
formed in E. coli cells by NO was progressively increased (panel A). In control E. coli cells without
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recombinant proteins (panel C), the total amount of protein-bound DNICs formed by NO remained
essentially the same (panel B). Furthermore, recombinant aconitase B was purified from the NOexposed E. coli cells. The EPR measurements confirmed that aconitase B was modified forming
aconitase B-bound DNIC in E. coli after NO exposure (Figure 3.2 D). Double integration analyses
of the EPR signal at g = 2.04 indicated that purified aconitase B-bound DNIC accounted for 4570% of the extra protein-bound DNICs formed in the NO-exposed E. coli cells.
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To determine whether other iron-sulfur proteins also contribute to the NO-mediated
formation of protein-bound DNICs in vivo, we expressed recombinant dihydroxyacid dehydratase
which contains a [4Fe-4S] cluster (48) in E. coli cells, and found similar correlation between the
expression level of dihydroxyacid dehydratase and the amount of protein-bound DNICs formed in
E. coli cells by NO (data not shown). To determine whether non-iron-sulfur proteins can also
contribute to the NO-mediated formation of protein-bound DNICs in E. coli cells, we expressed
both iron-sulfur proteins and non-iron-sulfur proteins under the same experimental conditions.
Figure 3.3 shows that expression of recombinant iron-sulfur proteins dihydroxyacid dehydratase
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(48) or the redox transcription factor SoxR (22) increased the amount of protein-bound DNICs in
the E. coli cells by at least 100%. In contrast, expression of non-iron-sulfur proteins (the heat shock
cognate protein HscA (49) and the single-stranded DNA binding protein SSB (50)) failed to
increase the amount of protein-bound DNICs formed in E. coli cells, although both proteins were
expressed to similar levels as dihydroxyacid dehydratase and SoxR (Figure 3.3 B). The EPR
measurements of recombinant proteins purified from the NO-exposed E. coli cells further
confirmed that while iron-sulfur proteins were modified forming protein-bound DNICs, the noniron-sulfur proteins did not form DNICs (data not shown). Thus, iron-sulfur proteins, but not the
proteins without iron-sulfur clusters, are modified forming protein-bound DNICs in E. coli cells
under NO stress.
Deficiency of iron-sulfur cluster assembly largely eliminates the NO-mediated formation of
protein-bound DNICs in E. coli cells
In E. coli, iron-sulfur clusters are assembled by a group of proteins encoded by two gene
clusters: iscRSUA-hscBA-fdx-iscX (ISC) (54) and sufABCDSE (SUF) (55). Among these ironsulfur cluster assembly proteins, IscA and SufA are paralogs with 47% sequence identity and 71%
similarity. Both IscA and SufA have been proposed as iron donors (46) or alternative scaffold
proteins (56) for the iron-sulfur cluster assembly. While deletion of IscA or SufA has only a mild
effect in E. coli cells, deletion of both IscA and SufA results in deficiency of the [4Fe-4S] cluster
assembly under aerobic conditions (45,46,57). Both the iscA-/sufA- double mutant and the wildtype
cells were able to express recombinant aconitase B in the rich LB medium under aerobic growth
conditions (Figure 3.4 A). However, unlike the wildtype cells, the iscA-/sufA- double mutant failed
to assemble the [4Fe-4S] cluster in proteins under aerobic growth conditions (46) (Figure 3.4 B).
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The wildtype and the iscA-/sufA- double mutant E. coli cells were then subjected to NO
exposure. Figure 3.4 C shows that NO exposure of the iscA-/sufA- double mutant cells produced
less than 5% of protein-bound DNICs observed in the wildtype cells. Further increase of NO
concentration (up to 500 μM NONOate) failed to increase the amount of protein-bound DNICs
formed in the iscA-/sufA- double mutant cells (data not shown). In parallel, the wildtype and the
iscA-/sufA- double mutant cells containing recombinant aconitase B were also exposed to NO.
Again, unlike in the wildtype E. coli cells, expression of recombinant aconitase B in the iscA-/sufAdouble mutant cells did not significantly increase the amount of protein-bound DNICs (Figure 3.4
C). Finally, recombinant aconitase B was purified from the NO-exposed wildtype and the iscA/sufA- double mutant E. coli cells. The EPR measurements confirmed that unlike that in the
wildtype cells, recombinant aconitase B in the NO-exposed iscA-/sufA- double mutant cells was
not modified by NO to form DNIC-bound aconitase. Similar results were obtained when
recombinant dihydroxyacid dehydratase was expressed in the wildtype and the iscA-/sufA- double
mutant E. coli cells (data not shown). Thus, deficiency of iron-sulfur cluster assembly largely
eliminates the NO-mediated formation of protein-bound DNICs in E. coli cells.
Depletion of the “chelatable iron pool” effectively removes iron-sulfur clusters from
aconitase B and diminishes NO-mediated formation of protein-bound DNICs in E. coli cells
The “chelatable iron pool” has been defined as the loosely bound iron that can be depleted
by membrane-permeable iron chelators (34). However, the exact chemical composition of the
“chelatable iron pool” has not been defined (36,58). It would be pertinent to explore the possible
link between iron-sulfur clusters in proteins and the “chelatable iron pool” in cells.
To test this idea, the wildtype E. coli cells containing recombinant aconitase B were treated
with a membrane-permeable iron chelator 2,2’-dipyridyl (59), followed by measurements of total
aconitase activity in the cell extracts. The protein synthesis inhibitor chloramphenicol was added
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to block new protein synthesis in the cells before addition of 2,2’-dipyridyl. Because aconitase B
requires an intact [4Fe-4S] cluster for its activity (20), removal of iron-sulfur cluster from aconitase
B would inactivate the enzyme. Figure 3.5 A shows that the total aconitase activity in the E. coli
cells was gradually decreased as the concentration of 2,2’-dipyridyl in growth medium was
increased and nearly abolished after the cells were incubated with 400 μM 2,2’-dipyridyl for 40
minutes.

68

Recombinant aconitase B was also purified from the E. coli cells pre-treated with different
concentrations of 2,2’-dipyridyl. Figure 3.5 B shows that the amount of iron-sulfur cluster in
recombinant aconitase B (as indicated from the amplitude of the absorption peak at 413 nm) was
gradually decreased as the concentration of 2,2’-dipyridyl in the growth medium was increased.
Over 85% of iron-sulfur clusters in recombinant aconitase B expressed in E. coli cells was removed
when E. coli cells were treated with 400 μM 2,2’-dipyridyl for 40 minutes. Similar results were
obtained when the E. coli cells containing recombinant dihydroxyacid dehydratase (48) were
treated with 2,2’-dipyridyl (data not shown). Thus, depletion of the “chelatable iron pool”
effectively removes the iron-sulfur clusters from proteins in E. coli cells.
The E. coli cells pre-treated with various concentrations of 2,2’-dipyridyl were then
exposed to NO as described above. The amount of protein-bound DNICs formed in the E. coli
cells after NO exposure was gradually decreased when the concentration of 2,2’-dipyridyl in
growth medium was increased (data not shown), and closely correlated with the amount of ironsulfur clusters remained in recombinant aconitase B in the cells.
We also followed the time course of the iron-sulfur cluster removal from recombinant
aconitase B in E. coli cells in the presence of 2,2’-dipyridyl (400 μM). As shown in Figure 3.6 A
and B, the amount of protein-bound DNICs in the E. coli cells was gradually decreased as the cells
were incubated with 2,2’-dipyridyl (400 μM), and closely correlated with the amount of iron-sulfur
clusters remained in recombinant aconitase B in the cells. Taking the results shown in Figure 3.6
together, we concluded that depletion of the “chelatable iron pool” effectively removes iron-sulfur
clusters from proteins and concomitantly diminishes the NO-mediated formation of protein-bound
DNICs in E. coli cells.
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Deficiency of iron-sulfur cluster assembly reduces the “chelatable iron pool” in E. coli cells
Because depletion of the “chelatable iron pool” effectively removes iron-sulfur clusters
from proteins, we reasoned that iron-sulfur clusters may be closely associated with the “chelatable
iron pool” in E. coli cells. To test this hypothesis, we first compared the “chelatable iron pool” in
the wildtype and the iscA-/sufA- double mutant E. coli cells. Figure 3.7 shows that the “chelatable
iron pool” in the iscA-/sufA- double mutant cells was less than half of that found in the wildtype
cells, indicating that deficiency of iron-sulfur cluster assembly significantly decreases the
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“chelatable iron pool” in E. coli cells. We then compared the “chelatable iron pool” in the wildtype
and the iscA-/sufA- double mutant E. coli cells containing recombinant aconitase B, and found that
expression of recombinant aconitase B increased the “chelatable iron pool” in the wildtype E. coli
cells but did not do so in the iscA-/sufA- double mutant cells. Similar results were obtained when
dihydroxyacid dehydratase (48) was expressed in the wildtype and the iscA-/sufA- double mutant
cells (data not shown). On the other hand, expression of recombinant non-iron-sulfur proteins
HscA (49) and SSB (50) had no effect on the “chelatable iron pool” in the wildtype and the iscA/sufA- double mutant E. coli cells, suggesting that iron-sulfur clusters in proteins constitute at least
part of the “chelatable iron pool” in E. coli cells.
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3.4 Discussion
Recent studies have shown that large molecular mass-bound DNICs are formed in cultured
mammalian cells under NO stress (35,36). However, the exact chemical nature of large molecular
mass-bound DNICs remains elusive (35,36). In this study, we demonstrate that iron-sulfur proteins
are the major source of large molecular mass-bound DNICs formed in E. coli cells under NO stress.
Expression of recombinant iron-sulfur proteins, but not proteins without iron-sulfur clusters,
almost doubles the amount of protein-bound DNICs formed in E. coli cells under NO stress (Figure
3.1). Purification of recombinant proteins from the NO-exposed E. coli cells further confirms that
iron-sulfur proteins, but not the proteins without iron-sulfur clusters, are modified forming proteinbound DNICs (Figures 3.2 and 3.3). Deletion of the iron-sulfur cluster assembly proteins IscA and
SufA to prevent [4Fe-4S] cluster assembly in E. coli cells (45,46) largely eliminates the NOmediated formation of protein-bound DNICs. Furthermore, depletion of the “chelatable iron pool”
in the wildtype E. coli cells effectively removes iron-sulfur clusters from proteins and
concomitantly diminishes the NO-mediated formation of protein-bound DNICs, indicating that
iron-sulfur clusters in proteins are in dynamic equilibrium with the “chelatable iron pool” in cells.
Previous studies indicated that proteins without iron-sulfur clusters such as bovine serum
albumin could also form DNICs with excess ferrous iron and NO in vitro (60,61). However, we
were unable to observe the DNICs formation in the proteins without iron-sulfur clusters in E. coli
cells under NO stress (Figure 3.3). One possible explanation is that excess iron and NO used in
the in vitro studies may form transient DNICs that are subsequently transferred to proteins via
thiol-ligand exchange (60,61). It seems that exceedingly low concentration of intracellular “free”
iron (62,63) may prevent formation of DNICs in the proteins without iron-sulfur clusters in E. coli
cells under NO stress. In contrast, iron-sulfur clusters in proteins are readily modified by NO
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forming protein-bound DNICs in vitro (19-27) and in vivo (8,12), and direct modification of ironsulfur clusters in proteins by NO has been attributed to the NO-mediated bacteriostasis of E. coli
under aerobic and anaerobic growth conditions (8,12) and NO-dependent killing of Burkholderia
mallei (13). Thus, at pathological NO concentrations (μM) (37,38), iron-sulfur proteins, but not
“free” iron, constitute the major source of protein-bound DNICs formed in E. coli cells.
The E. coli mutant with deficiency in iron-sulfur cluster assembly provides a unique
opportunity to further illustrate the role of iron-sulfur clusters in the NO-mediated formation of
protein-bound DNICs in vivo. Previous studies showed that deletion of both IscA and SufA results
in deficiency of the [4Fe-4S] cluster assembly in E. coli cells under aerobic growth conditions
(45,46). Here we find that deficiency of the [4Fe-4S] cluster assembly due to deletion of IscA and
SufA largely eliminates the NO-mediated formation of protein-bound DNICs in E. coli cells
(Figure 3.4), demonstrating that iron-sulfur clusters are mainly responsible for the NO-mediated
formation of protein-bound DNICs in E. coli cells.
The cellular “chelatable iron pool” has been described as the iron content that can be
depleted with membrane-permeable iron chelators (34), and has been proposed as the major iron
source for formation of large molecular mass-bound DNS under NO stress (34-36). However, the
exact chemical composition of the “chelatable iron pool” has not been defined (35,36,58). It is also
possible that bacteria and mammalian cells may have a distinct “labile iron pool”. In this study,
we find that depletion of the “chelatable iron pool” with the strong iron chelator 2,2’-dipyridyl
effectively removes iron-sulfur clusters from recombinant aconitase B (Figure 3.5) or
dihydroxyacid dehydratase in E. coli cells. We propose that iron-sulfur clusters are at least part of
the “chelatable iron pool” in bacterial cells. The equilibrium between the “chelatable iron pool”
and iron-sulfur clusters in proteins was previously implicated in regulation of the iron regulatory
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protein IRP-1 / cytosolic aconitase in mammalian cells (62,63). IRP-1 is an iron-sulfur protein
with cytosolic aconitase activity. When the “chelatable iron pool” is depleted, the [4Fe-4S] cluster
in IRP-1 is removed, resulting in apo-IRP-1 that binds the iron responsive elements (IREs) of target
mRNAs to promote intracellular iron content (55,56). When intracellular iron content is
replenished, the [4Fe-4S] cluster is re-assembled in apo-IRP-1 to prevent accumulation of excess
intracellular iron. Similar equilibrium between the “chelatable iron pool” and iron-sulfur clusters
in proteins have been reported for the iron-sulfur cluster assembly regulator IscR (64,65), the
anaerobic growth factor FNR (66), and the NO sensor NsrR (14), among other iron-sulfur proteins
in bacteria (10,67). Our results presented in this study are entirely consistent with the hypothesis
that the “chelatable iron pool” is in dynamic equilibrium with iron-sulfur clusters in proteins
(Figure 3.6). Although the molecular details underlying iron exchange between the “chelatable
iron pool” and iron-sulfur clusters in proteins could only be speculated at present, decrease of
“chelatable iron content” in the E. coli mutant cells with deficiency of iron-sulfur cluster assembly
and an increase of “chelatable iron content” in the wildtype E. coli cells containing recombinant
iron-sulfur protein aconitase B (Figure 3.7) clearly suggest that iron-sulfur clusters in proteins at
least contribute to part of the “chelatable iron pool” in E. coli cells.
Throughout evolution, iron-sulfur proteins have become integral parts of diverse
physiological processes (15,16). Over 500 unique iron-sulfur proteins have been identified in
various organisms (15). Modification of iron-sulfur proteins by NO is expected to have a broad
impact on cellular functions. If cells are to survive, the NO-modified iron-sulfur proteins must be
efficiently repaired. Although the biomimetic model studies suggest that DNIC may be directly
converted back to iron-sulfur clusters (68), the cellular repair mechanism appears to be more
complex. It has been shown that the genes encoding the iron-sulfur cluster assembly machinery
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are highly induced in E. coli cells under NO stress (6-9), suggesting that these proteins could be
directly involved in repair of the NO-modified iron-sulfur clusters. Recently, we have shown that
L-cysteine and oxygen are two key components for decomposition of protein-bound DNICs in
vitro and in vivo (27). However, re-assembly of new iron-sulfur clusters must occur in order to
fully restore the function of NO-modified iron-sulfur proteins. Understanding the dynamic
exchange between intracellular iron and iron-sulfur clusters in proteins will be crucial to elucidate
cellular repair mechanism for the NO-modified iron-sulfur proteins.
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CHAPTER 4
THE N-TERMINAL DOMAIN OF HUMAN DNA HELICASE RTEL1 CONTAINS A
REDOX ACTIVE IRON-SULFUR CLUSTER 3

4.1 Introduction
In vertebrates, telomeres are the protective structures at the end of chromosomes, and are
composed of both repetitive TTAGGG sequences and associated proteins that form a core structure
known as the Shelterin complex (1,2). Telomeres become shorter with each round of DNA
replication, and are compensated for by telomerase (3). In addition to telomerase, the telomere
length is regulated by other genetic (4) and epigenetic (5) factors. Among them, Regulator of
telomere length 1 (Rtel1) has an essential role in maintaining proper length of telomeres (4,6).
Deletion of Rtel1 in mice is embryonic lethal with increased incidence of chromosomal
abnormalities and telomere loss (4). In humans, Rtel1 is highly expressed in several types of
tumor tissues (7), and specific mutations in Rtel1 have been attributed to Dyskeratosis congenita
and Hoyeraal-Hreidarsson syndrome (8,9).
Human Rtel1 is a superfamily II DNA helicase (10), and is homologous to other human
DNA helicases XPD (Xeroderma pigmentosum factor D) (11), FancJ (Fanconi’s anaemia
complementation group J) / BACH1 (for BRCA1-associated C-terminal helicase) (12,13), and
ChlR1 (a protein required for normal mitotic progression) (14). However, unlike other DNA
helicases, Rtel1 preferentially disrupts the D-loop within the T-loop structure formed at the end of
telomeres (15) and may act as an anti-recombinase to prevent the formation of D-loops (6,16). In
the absence of Rtel1, the T-loop structure could be erroneously resolved as a substrate for
3

This chapter previously appeared as: Landry, A. P., and Ding, H. (2014) The N-terminal domain
of human DNA helicase Rtel1 contains a redox active iron-sulfur cluster. BioMed research
international 2014, 285791. Modified and reprinted with permission of Hindawi Publishing
Corporation.
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homologous recombination (16), leading to telomere deficiency. On the other hand, excessive
activity of Rtel1 would be detrimental as increased Rtel1 helicase activity would disengage the
T-loop structure, leading to telomere de-protection and genomic instability (16). Thus, the
helicase activity of Rtel1 must be tightly regulated to maintain proper length of telomeres in
chromosomes (6).
The sequence alignment analyses revealed that the N-terminal domain of human Rtel1
contains a conserved region for hosting a putative iron-sulfur cluster via four cysteine residues
(Figure 4.1) (17). It has previously been reported that the DNA helicase Rad3 from yeast (18), and
XPD homologs from archaea (19-22), DNA-damage-inducible DNA helicase DinG from
Escherichia coli (23), and AddAB-type helicase-nuclease from Bacillus subtilis (24) contain a
[4Fe-4S] cluster essential for the helicase activity. However, the existence of the iron-sulfur
cluster in any human DNA helicases has not been experimentally demonstrated. Here, we report
that expression of the N-terminal domain (residues 1-312) of human Rtel1 (RtelN) in E. coli cells
produces a protein that contains a redox active iron-sulfur cluster with redox midpoint potential
(Em) of -248 ± 10 mV (pH 8.0). Purified RtelN retains a weak binding activity for the singlestranded (ss) and double-stranded (ds) DNA, and disruption of the iron-sulfur cluster by hydrogen
peroxide or nitric oxide does not affect the DNA binding activity of RtelN, suggesting that ironsulfur cluster in the N-terminal domain may not be directly involved in DNA interaction in Rtel1.

4.2 Materials and Methods
Protein preparation
The DNA fragment encoding the N-terminal domain (RtelN, residues 1-312) of human
Regulator of Telomere Length 1 (Rtel1) was synthesized for expression in E. coli cells
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(Genescript). The gene was subcloned into an expression plasmid pET28b+ which was introduced
into E. coli BL21(DE3) cells. The E. coli cells hosting the expression plasmid were grown in LB
medium to an O.D. at 600 nm of ~0.6 before isopropyl β-D-1-thiogalactopyranoside (200 μM) was
added to induce the protein expression for three hours. The cells were harvested and passed through
French press once. Recombinant RtelN in pellets was solubilized by adding urea (6 M), and the
protein was purified using a nickel-agarose column attached to a FPLC system (GE Biosciences),
followed by passing through a HiTrap desalting column. The molecular weight of RtelN was
confirmed by MALDI mass spectrometry (Chemistry Department, LSU). The concentration of
purified RtelN was measured from the absorption peak at 280 nm using an extinction coefficient
of 25.5 mM-1cm-1. The total iron content in purified RtelN sample was determined using an iron
indicator FerroZine (25). The total acid-labile sulfide content was determined according to the
Siegel’s method (26). The single-stranded DNA binding protein SSB (27) was prepared as
described previously (28).
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The DNA binding activity assay of RtelN
The DNA binding activity assay was carried out using a fluorescence labeled 40mer (5’F*-AATTGCGATCTAGCTCGCCAGUAGCGACCTTATCTGATGA-3’). For single-stranded
(ss) DNA binding assay, the 40mer (0.5 μM) was incubated with increasing concentrations of
protein in buffer containing Tris (20 mM, pH 8.0), NaCl (50 mM), β-mercaptoethanol (1mM),
MgCl2 (1mM), and bovine serum albumin (0.5 mg/mL). For the double-strand (ds) DNA binding
assay, the fluorescence-labeled 40mer was annealed to a complementary ssDNA in an annealing
buffer containing Tris (50 mM, pH 8.0), NaCl (50 mM), and MgCl2 (10 mM). Prepared dsDNA
labeled with fluorescence was incubated with increasing concentrations of protein in buffer as
described above. After incubation at room temperature for 15 minutes, samples were loaded on to
a 0.6% agarose gel in TAE buffer. The agarose gel was run at 10 volts/cm for 30 minutes at room
temperature and photographed in a KODAK Gel Logic 200 Imaging System.
Redox titration of the RtelN iron-sulfur cluster
A specially-designed cuvette was used for redox titration experiments as described by
Dutton (29). Purified RtelN (20 μM) dissolved in buffer containing Tris (50 mM, pH 8.0) and
NaCl (500 mM) was incubated with a redox mediator safranin O (1 μM) in a sealed cuvette and
equilibrated with pure argon gas for 45 minutes at room temperature. The redox potential was
adjusted by adding a small amount of freshly prepared sodium dithionite using a gas-tight 10-µl
Hamilton micro-syringe (Hamilton Inc.). The redox potential was monitored with a redox
microelectrode (Microelectrodes Inc.) which was calibrated using a standard ZoBell solution (Eh
= +238 mV) containing potassium ferricyanide (5 mM) and potassium ferrocyanide (5 mM) in
buffer containing Tris (20 mM, pH 8.0) and NaCl (500 mM). The redox titration data were fitted
to the Nernst Equation with n = 1 using KaleidaGraph (Synergy Software).
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Hydrogen peroxide and nitric oxide treatments of RtelN
For hydrogen peroxide (H2O2) treatments, purified RtelN was incubated with different
concentrations of H2O2 at room temperature for 30 minutes, followed by re-purification of the
protein from the incubation solutions. For nitric oxide (NO) treatments, purified RtelN dissolved
in a sealed vial was purged with pure argon gas for 15 minutes, followed by incubation with the
NO-releasing reagent diethylamine NONOate (Cayman Chemicals co.) at 37oC for 10 minutes.
RtelN was re-purified after the NO treatment. Modification of the iron-sulfur cluster in RtelN by
H2O2 or NO was quantified by UV-visible absorption spectrophotometry.
Circular dichroism (CD) and electron paramagnetic resonance (EPR) measurements
Circular dichroism (CD) spectra were recorded on a Jasco J-815 CD spectrometer
(AgCenter Biotechnology Laboratories, LSU) at room temperature. The composition of secondary
structures was obtained using the CDNN program (30). The electron paramagnetic resonance
(EPR) spectra were recorded at X-band on a Bruker ESR-300 spectrometer equipped with an
Oxford Instruments 910 continuous flow cryostat. EPR conditions were as follows: microwave
frequency, 9.45 GHz; microwave power, 10 mW; modulation frequency, 100 kHz; modulation
amplitude, 2 mT; sample temperature, 10 K; receive gain, 1 x 105.

4.3 Results
The N-terminal domain of human Rtel1 hosts an iron-sulfur cluster
When the N-terminal domain of human Rtel1 (RtelN) was expressed in E. coli cells, the
cell pellets were dark red in color (Figure 4.2 A insert). Recombinant RtelN was then purified from
the E. coli cells as described in Materials and Methods. The UV-visible absorption measurements
showed that purified RtelN had an absorption peak at 415 nm (Figure 4.2 A), similar to that of the
S. acidocaldarius XPD [4Fe-4S] cluster (22) and the E. coli DinG [4Fe-4S] cluster (23). Purified
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RtelN was further subjected to circular dichroism (CD) measurements. As shown in Figure 4.2 B,
purified RtelN adopted an ordered structure with about 25% alpha-helix, 32% beta-sheet, 20%
beta turns, and 22% random coil. The iron and sulfide content analyses revealed that purified RtelN
contained 0.83 ± 0.13 iron and 0.75 ± 0.16 acid-labile sulfide per protein.
The low iron and sulfide content in purified RtelN could be due to the protein purification
process carried out under denaturing conditions. To reconstitute iron-sulfur clusters in RtelN, renatured protein was reconstituted with excess iron and sulfide as described previously (23). After
reconstitution, the iron and sulfide contents in RtelN were increased to 3.5 ± 0.3 iron and 3.2 ± 0.5
sulfide per RtelN, respectively, indicating that each RtelN monomer may bind a [4Fe-4S] cluster.
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The iron-sulfur cluster in RtelN is redox active
When freshly prepared sodium dithionite was added to the solution containing RtelN, the
absorption peak at 415 nm of the RtelN iron-sulfur cluster was completely eliminated (Figure 4.3
A). The absorption peak at 415 nm was restored when the reduced RtelN iron-sulfur cluster was
re-oxidized by oxygen (data not shown), suggesting that the RtelN iron-sulfur cluster can be
reversibly reduced. This notion was further confirmed by EPR measurements: while purified RtelN
was EPR silent, addition of sodium dithionite to purified RtelN produced an EPR spectrum with
gx = 1.918, gy = 1.994 and gz = 2.050 (Figure 4.3 B), a spectrum similar that of the reduced E. coli
DNA helicase DinG [4Fe-4S] cluster (23).
Redox titration experiments were then carried out to determine the redox midpoint
potential (Em) of the RtelN iron-sulfur cluster. The amplitude of the absorption peak at 415 nm
of RtelN were plotted as a function of redox potentials in the solution (Figure 4.3 C). The data
from three sets of experiments were fitted to a Nernst equation (n = 1) with an Em of -248 ± 10 mV
at pH 8.0, which is about 140 mV higher than that of the E. coli DinG [4Fe-4S] cluster (23).
Purified RtelN has a weak DNA binding activity
The N-terminal domain of the archaeal DNA helicase XPD comprises part of the catalytic
center (20). To test whether the N-terminal domain of Rtel1 also contributes to the catalytic site,
we examined the DNA binding activity of purified RtelN. As shown in Figure 4.4 A, purified
RtelN formed a protein-DNA complex with the single-stranded (ss) DNA. FhuF, an iron-sulfur
protein with similar in molecular weight to RtelN but with no known DNA binding activity (31),
failed to bind any ssDNA, indicating that the ssDNA binding in RtelN is specific. Nevertheless,
compared with the single-stranded DNA binding protein SSB (27), the binding affinity of RtelN
for ssDNA was at least 10-fold weaker. In parallel, we also determined the double-stranded (ds)
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DNA binding activity of RtelN under the same experimental conditions. Figure 4.4 B shows that
RtelN could also bind dsDNA with the similar binding affinity as for ssDNA. In contrast, both
FhuF and SSB did not bind any dsDNA as expected. Thus, purified RtelN has a binding activity
for both ssDNA and dsDNA in vitro.

The iron-sulfur cluster is not required for the DNA binding activity of RtelN
Ironically, iron-sulfur clusters in proteins are often sensitive to reactive oxygen species
(32) and nitrogen species (33,34). To test if the iron-sulfur clusters in RtelN can be modified by
reactive oxygen species, we incubated RtelN with hydrogen peroxide at room temperature. Figure
4.5 A shows that addition of increasing amounts of hydrogen peroxide removed the absorption
peak at 415 nm of purified RtelN, indicating that the iron-sulfur cluster in RtelN are disrupted by
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hydrogen peroxide. Purified RtelN was also incubated with the nitric oxide-releasing reagent
diethylamine NONOate in solution. Again, the absorption peak at 415 nm of the RtelN iron-sulfur
cluster was largely abolished as the concentration of nitric oxide was increased (Figure 4.5 B).
Thus, the iron-sulfur cluster in RtelN is sensitive to both hydrogen peroxide and nitric oxide.
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We then sought to examine the DNA binding activity of RtelN after the protein was treated
with hydrogen peroxide and nitric oxide. Figure 4.5 C shows that the DNA binding activity of
RtelN remained nearly unchanged when the iron-sulfur cluster was modified by hydrogen peroxide
or nitric oxide, suggesting that the iron-sulfur cluster is not required for the DNA binding activity
of RtelN.

4.4 Discussion
Recent studies have identified a new set of iron-sulfur cluster-containing enzymes that are
involved in DNA processing in bacteria and eukaryotic cells (17). Among these enzymes are a
group of DNA helicases that require an intact iron-sulfur cluster for the DNA helicase activity
(11,35). For example, it has been shown that the DNA helicase Rad3 from yeast and XPD
homologs from archaea contain a [4Fe-4S] cluster essential for the enzyme activity (19-22). In
human XPD, mutations in the N-terminal domain that hosts a putative iron-sulfur cluster have been
associated with several genetic diseases including Xeroderma pigmentosum (20). Interestingly, in
addition to XPD, humans have at least three other DNA helicases: FancJ (Fanconi’s anaemia
complementation group J) / BACH1 (for BRCA1-associated C-terminal helicase) (12,13), ChlR1
(a protein required for normal mitotic progression) (14) and Rtel1 of telomere length regulation
(4,6) that contain a putative iron-sulfur cluster binding site in the N-terminal domain (Figure 4.1).
However, the existence of the [4Fe-4S] clusters in any of these human DNA helicases has not been
experimentally demonstrated. Here we find that the N-terminal domain of human Rtel1 (RtelN)
expressed in E. coli cells contains a redox active [4Fe-4S] cluster, and that the iron-sulfur cluster
in purified RtelN is highly sensitive to hydrogen peroxide and nitric oxide. The results suggest that
human Rtel1, like XPD from archaea (19-22), likely contains a [4Fe-4S] cluster.
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Despite the findings of the iron-sulfur clusters in these DNA helicases, specific function of
the [4Fe-4S] clusters in the DNA helicases remains largely elusive (17). In previous studies, we
reported that oxidation of the reduced iron-sulfur cluster in E. coli DNA helicase DinG reversibly
switches on the enzyme activity, and proposed that iron-sulfur cluster may regulate the helicase
activity in response to redox signals (23). Here, we have tested the idea further in the human DNA
helicase Rtel1. While attempts to purify a full-length human Rtel1 from E. coli cells were not
successful, we were able to prepare the soluble N-terminal domain (residues 1 – 312) of human
Rtel1 (RtelN). The results demonstrated that RtelN contains a redox active iron-sulfur cluster with
a redox midpoint potential of -248 ± 10 mV at pH 8.0 (Figure 4.3). The redox potential in cytosol
and nucleus of mammalian cells has been reported to be around -325 mV (pH 7.0) (36). However,
when cells are under oxidative stress or during apoptosis and differentiation, the intracellular redox
potential could increase to as high as +200 mV (37). Assuming the redox midpoint potential of the
iron-sulfur cluster in Rtel1 is similar to that in RtelN, we would expect that the iron-sulfur cluster
in Rtel1 is in reduced state in cells under normal physiological conditions. Under oxidative stress
or during apoptosis and differentiation (37), the iron-sulfur cluster in Rtel1 would be fully
oxidized. We envision that oxidation of the reduced iron-sulfur cluster in Rtel1, like that in the E.
coli DinG (23), may change the DNA helicase activity of the protein in response to redox signals.
Thus, fluctuation of intracellular redox potential may result in the change of Rtel1 DNA helicase
activity by changing the redox state of the iron-sulfur cluster. While the iron-sulfur cluster appears
to be dispensable for the DNA binding activity of purified RtelN (Figure 4.5), the iron-sulfur
cluster could have an important role in other steps of the reaction catalyzed by Rtel1.
The telomere length of chromosomes has been linked to intracellular oxidative stress in
human cells (38). The finding that the RtelN iron-sulfur cluster is sensitive to hydrogen peroxide
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and nitric oxide (Figure 4.5) may provide a rational explanation for the association between the
telomere length of chromosomes and oxidative stress in cells. Since the iron-sulfur cluster is
essential for the DNA helicase activity of XPD from yeast and archaea (19-22), disruption of ironsulfur clusters in protein would likely change the helicase activity of Rtel1 in human cells. If the
iron-sulfur cluster in Rtel1 is as sensitive to hydrogen peroxide or nitric oxide as that in RtelN, the
DNA helicase activity of Rtel1 could be modulated by intracellular reactive oxygen / nitrogen
species. Therefore, modification of iron-sulfur cluster in Rtel1 by these species could at least in
part contribute to telomere length of chromosomes in cells (38). Evidently, additional
experiments are required to illustrate the regulatory role of the iron-sulfur cluster in the human
Rtel1 and other DNA helicases.
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CHAPTER 5
REDOX CONTROL OF HUMAN MITOCHONDRIAL PROTEIN MITONEET [2FE-2S]
CLUSTERS BY BIOLOGICAL THIOLS AND HYDROGEN PEROXIDE 4

5.1 Introduction
Human mitochondrial protein mitoNEET is a novel target of type II diabetes drug class of
thiazolidinediones, such as pioglitazone (1). Genetic studies have shown that deletion of
mitoNEET in mice results in a reduced oxidative phosphorylation capacity in mitochondria (2).
While increased expression of mitoNEET in adipocytes in mice enhances lipid uptake and storage
and inhibits mitochondrial iron transport into the matrix, depletion of mitoNEET in adipocytes
leads to reduced weight gain in mice (3), suggesting that mitoNEET may regulate energy
metabolism in mitochondria (1). Recent studies further indicated that mitoNEET may have a
central role in neurodegenerative diseases (4,5) and breast cancer proliferation (6) by maintaining
mitochondrial homeostasis in cells.
MitoNEET localizes on mitochondrial outer membranes (2) via the N-terminal
transmembrane α-helix (residues 14 to 32) (1). Expression of the soluble C-terminal domain
(residues 33-108) of mitoNEET in Escherichia coli cells produced a protein that contains a [2Fe2S] cluster (7). Crystallographic studies revealed that mitoNEET exists as a homodimer, with each
monomer hosting a [2Fe-2S] cluster via an unusual ligand arrangement of three cysteine (Cys-72,
Cys-74 and Cys-83) and one histidine (His-87) residues (8-10). The [2Fe-2S] clusters in
mitoNEET are redox active with the redox midpoint potential at pH 7.0 (Em7) of ~0 mV (11,12).
Substitution of the unique His-87 with cysteine in mitoNEET shifts the Em7 value of the [2Fe-2S]
4

This chapter previously appeared as: Landry, A. P., and Ding, H. (2014) Redox control of human
mitochondrial outer membrane protein MitoNEET [2Fe-2S] clusters by biological thiols and
hydrogen peroxide. The Journal of biological chemistry 289, 4307-4315. Modified and reprinted
with permission of the American Society of Biochemistry and Molecular Biology.
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clusters from ~0 mV to -320 mV (11) and increases the stability of the cluster in the protein (13).
The redox property and stability of the [2Fe-2S] clusters in mitoNEET are also modulated by type
II diabetes drug pioglitazone (11), excess zinc (14), resveratrol-3-sulfate (15), NADPH (16), the
inter-domain interactions (17,18), and the hydrogen bond network in the protein (19), suggesting
that mitoNEET may act as a sensor of multiple signals to regulate mitochondrial functions (19).
Interestingly, purified mitoNEET can also transfer the [2Fe-2S] clusters to apo-protein with 50%
completion time of about 120 minutes at room temperature (20,21). As mitochondria are the
primary sites for iron-sulfur cluster biogenesis (22), it is appealing to consider that mitoNEET may
participate in the iron-sulfur cluster biogenesis process in human cells (20,21). Nevertheless, the
iron-sulfur cluster transfer occurs only when the [2Fe-2S] clusters in mitoNEET are oxidized (20),
and the cluster transfer process is inhibited by NADPH (21), suggesting that the mitoNEETmediated iron-sulfur cluster transfer could be regulated by the redox state of the [2Fe-2S] clusters
and by intracellular NADPH.
Since the cytosolic redox potential in eukaryotic cells is estimated to be around -325 mV
(pH 7.0) (23), it is expected that the mitoNEET [2Fe-2S] clusters (Em7 = ~0 mV) (11,12) would be
in reduced state in cells under physiological conditions. Nevertheless, the redox state of the
mitoNEET [2Fe-2S] clusters in cells has not been demonstrated, and specific cellular components
that may reduce the mitoNEET [2Fe-2S] clusters have not been identified. Here we report that
human mitoNEET [2Fe-2S] clusters are in the fully reduced state when expressed in E. coli cells
under normal growth conditions, and that purified mitoNEET [2Fe-2S] clusters can be partially
reduced by monothiols such as reduced glutathione, L-cysteine and N-acetyl-L-cysteine, and fully
reduced by dithiothreitol and E. coli thioredoxin reduced by thioredoxin reductase and NADPH.
Importantly, the reduced mitoNEET [2Fe-2S] clusters can be reversibly oxidized by hydrogen
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peroxide without disruption of the clusters, indicating that the redox state of the mitoNEET [2Fe2S] clusters can be modulated by biological thiols and oxidative signals. Furthermore, we find that
type II diabetes drug pioglitazone can effectively inhibit the thiol-mediated reduction of the
mitoNEET [2Fe-2S] clusters in vitro, suggesting that pioglitazone may modulate the function of
mitoNEET by blocking the thiol-mediated reduction of the [2Fe-2S] clusters in the protein.

5.2 Materials and Methods
Protein purification
The gene encoding human mitoNEET33–108 (containing amino acid residues 33-108) was
previously cloned from the human cDNA library as described in (14). The mitoNEET mutant in
which histidine 87 was substituted with cysteine (H87C) was constructed using the QuikChange
site-directed mutagenesis kit (Stratagene). The constructed mutation was confirmed by direct
sequencing (Operon). Human mitoNEET and the mitoNEET mutant proteins were prepared
following the procedures described previously (14). E. coli thioredoxin (TrxA) and thioredoxin
reductase (TrxB) were produced from E. coli cells using the expression vectors pDL59 (24) and
pTrR301 (25), respectively, and purified as described in (26). Both E. coli thioredoxin and
thioredoxin reductase were purified in the native form. The purity of purified proteins was greater
than 95% as judged by electrophoresis analysis on a 15% polyacrylamide gel containing SDS
followed by staining with Coomassie Blue. The protein concentration of purified mitoNEET or
the mitoNEET mutant H87C was measured at 280 nm using an extinction coefficient of 8.6 mM 1

cm-1. The protein concentration of thioredoxin and thioredoxin reductase was determined at 280

nm using extinction coefficient of 14.2, and 17.7 mM-1 cm-1, respectively. A Beckman DU640
UV-visible spectrophotometer equipped with a temperature control was used for measuring
absorption spectra.
99

EPR measurements
For the whole cell EPR (electron paramagnetic resonance) measurements, E. coli cells were
grown for two hours before the recombinant protein expression was induced. After two hours of
protein expression, cells were harvested and washed once with phosphate buffer (pH 7.5) and resuspended in phosphate buffer or fresh LB medium. An aliquot (350 μL) of the E. coli cells was
then transferred to an EPR tube and frozen immediately in liquid nitrogen. For the reduced
samples, freshly prepared sodium dithionite was added to the E. coli cells before the EPR samples
were prepared. For the protein sample preparation, purified mitoNEET [2Fe-2S] clusters dissolved
in buffer containing 20 mM Tris (pH 8.0) and 500 mM NaCl were purged with pure argon gas in
sealed vials for 15 minutes before the reductant was added under anaerobic conditions. After
incubation at 37°C for 20 minutes, the samples were transferred to EPR tubes and frozen
immediately in liquid nitrogen. The X-band EPR spectra were recorded using a Bruker model
ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow cryostat.
Routine EPR conditions were: microwave frequency, 9.47 GHz; microwave power, 10.0 mW;
modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 20 K; receive gain,
2 x 105.
Chemicals
Pioglitazone, L-cysteine, N-acetyl-L-cysteine, reduced glutathione, and other chemicals
were purchased from Sigma. Isopropyl β-D-1-thiogalactopyranoside (IPTG), NADPH,
kanamycin, ampicillin, and dithiothreitol were from Research Products International. Pioglitazone
was dissolved in DMSO as a stock solution containing 25 mM pioglitazone. An equal amount of
DMSO was added to the samples as a control.

100

5.3 Results
Human mitoNEET [2Fe-2S] clusters expressed in E. coli cells are fully reduced
Purified human mitoNEET [2Fe-2S] clusters are in oxidized state and have no
paramagnetic resonance (EPR) signals (Figure 5.1 A). When purified mitoNEET [2Fe-2S] clusters
were reduced with sodium dithionite, a strong reductant with Em7 = -660 mV (27), an rhombic
EPR spectrum with gx = 1.895, gy = 1.937, and gz = 2.005 appeared (Figure 5.1 A), as reported
previously (7,19,28,29). In parallel, we also prepared the mitoNEET mutant H87C in which the
unique ligand His-87 of the [2Fe-2S] cluster is replaced with cysteine. While purified mitoNEET
H87C had no EPR signal, addition of sodium dithionite produced a new rhombic EPR spectrum
of the [2Fe-2S] cluster with gx = 1.896, gy = 1.970, and gz = 1.992, which is distinct from that of
the wildtype mitoNEET (Figure 5.1 A).
EPR measurement provides an efficient and non-intrusive approach to determine the redox
state of iron-sulfur clusters in proteins dissolved in solutions or within whole cells (30,31). Here,
we took advantage of EPR spectroscopy to explore the redox state of the mitoNEET [2Fe-2S]
clusters expressed in E. coli cells. Figure 5.1 B shows that the E. coli cells without any recombinant
proteins have very little or no EPR signals, due to low concentrations of endogenous iron-sulfur
proteins in cells (30,31). Under the same experimental conditions, the E. coli cells expressing
human mitoNEET show a rhombic EPR signal at g = 1.94 which is identical to that of the reduced
mitoNEET [2Fe-2S] clusters (Figure 5.1 A). In contrast, the E. coli cells expressing the mitoNEET
mutant H87C did not have any EPR signals (Figure 5.1 B), although both mitoNEET and the
mitoNEET mutant H87C are expressed similarly in E. coli cells based on the SDS-PAGE gel
analysis (data not shown). This is likely because the mutation of His-87 to cysteine shifts the Em7
value of the mitoNEET [2Fe-2S] clusters from ~0 mV to -320 mV (11). Since the cytosolic redox
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potential of E. coli cells is about -260 mV (32), the mitoNEET mutant H87C [2Fe-2S] clusters
would be mostly in oxidized (and thus EPR silent) state in E. coli cells.

To further examine the redox state of the [2Fe-2S] clusters in the wildtype mitoNEET and
the mitoNEET mutant H87C expressed in E. coli cells, excess sodium dithionite was added to the
cells to reduce all iron-sulfur proteins. Figure 5.1 C shows that addition of sodium dithionite to the
E. coli cells without recombinant proteins does not produce any new EPR signals. On the other
hand, addition of sodium dithionite to the E. coli cells expressing the mitoNEET mutant H87C
generated an EPR signal at g = 1.97 which is the same as that of the reduced mitoNEET mutant
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H87C [2Fe-2S] clusters (Figure 5.1 A). Thus, the oxidized [2Fe-2S] clusters of the mitoNEET
mutant H87C in E. coli cells can be reduced by sodium dithionite. In contrast, the EPR signal at g
= 1.94 of the E. coli cells expressing the wildtype mitoNEET was not changed by addition of
sodium dithionite, suggesting that the wildtype mitoNEET [2Fe-2S] clusters are fully reduced in
E. coli cells even before addition of sodium dithionite. Since the cytosolic redox potential in
eukaryotic cells (-325 mV (23)) is about 65 mV lower than that in E. coli cells (-260 mV (32)), we
postulate that the mitoNEET [2Fe-2S] clusters are most likely in reduced state in human cells
under physiological conditions.
Human mitoNEET [2Fe-2S] clusters can be reduced by biological thiols
Although it has been shown that the mitoNEET [2Fe-2S] clusters are redox active (11,12),
specific biological molecules that can reduce or oxidize the mitoNEET [2Fe-2S] clusters are
unknown. Since the mitoNEET [2Fe-2S] clusters are fully reduced in E. coli cells, we reason that
the mitoNEET [2Fe-2S] clusters may be reduced by cellular reducing components that are
common in both human and E. coli cells. However, NADPH is not one of them, as NADPH fails
to reduce the mitoNEET [2Fe-2S] clusters in vitro (21). Among other cellular reducing
components, biological thiols are abundant. More importantly, biological thiols are able to form
intermediate thiol free radicals (33,34) which can potentially provide electrons for the singleelectron reduction of the oxidized [2Fe-2S] clusters in mitoNEET.
To test this idea, purified mitoNEET was incubated with thiols under anaerobic conditions.
After incubation, the samples were subjected to the EPR and UV-visible absorption measurements.
The reduced mitoNEET [2Fe-2S] clusters were observed from the EPR signal at g = 1.94 and the
UV-visible absorption peaks at 420 nm and 550 nm. As shown in Figure 5.2, all biological thiols
tested (reduced glutathione, L-cysteine, and N-acetyl-L-cysteine) were able to partially reduce the
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mitoNEET [2Fe-2S] clusters. Reduced glutathione appeared to reduce the mitoNEET [2Fe-2S]
clusters with the least ability. L-cysteine are N-acetyl-L-cysteine were able to reduce about 50%
of the mitoNEET [2Fe-2S] clusters in solution under anaerobic conditions, in comparison with the
mitoNEET [2Fe-2S] clusters fully reduced by sodium dithionite. Further increasing L-cysteine
concentration (up to 50 fold excess over the mitoNEET [2Fe-2S] clusters) or incubation time (up
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to 60 minutes) did not increase the amount of the reduced mitoNEET [2Fe-2S] clusters in the
incubation solution (data not shown), suggesting that L-cysteine could not fully reduce the
mitoNEET [2Fe-2S] clusters under the experimental conditions. Interestingly, incubation with
dithiothreitol, a dithiol that has an Em7 value of -323 mV (35), almost fully reduced the mitoNEET
[2Fe-2S] clusters under the same experimental conditions (Figure 5.2).
Human mitoNEET [2Fe-2S] clusters are fully reduced by the E. coli thioredoxin / thioredoxin
reductase system
The biological equivalent of dithiothreitol is the ubiquitous thioredoxin (36). The Em7 value
of E. coli thioredoxin is about -270 mV (37), which is close to that of dithiothreitol (35). To test
whether the oxidized mitoNEET [2Fe-2S] clusters can be reduced by thioredoxin, we prepared E.
coli thioredoxin and thioredoxin reductase as described previously (26). When purified mitoNEET
[2Fe-2S] clusters were incubated with equimolar concentrations of the E. coli thioredoxin /
thioredoxin reductase proteins or an excess amount of NADPH under anaerobic conditions, the
mitoNEET [2Fe-2S] clusters remained in the oxidized state (Figure 5.3). This could be because
purified thioredoxin is mostly oxidized during the protein purification process. Indeed, when
purified mitoNEET [2Fe-2S] clusters were incubated with thioredoxin pre-reduced with
thioredoxin reductase and NADPH, the mitoNEET [2Fe-2S] clusters were fully reduced (Figure
5.3). On the other hand, the mitoNEET mutant H87C [2Fe-2S] clusters which have an Em7 of -320
mV (11) could not be reduced by the E. coli thioredoxin / thioredoxin reductase system under the
same experimental conditions (Figure 5.3). This is consistent with the observation that the
mitoNEET mutant H87C [2Fe-2S] clusters are in the oxidized state when expressed in E. coli cells
(Figure 5.1 B). Taken together, the results suggest that the wildtype mitoNEET [2Fe-2S] clusters
can be fully reduced by the E. coli thioredoxin / thioredoxin system in vitro.
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Reduced mitoNEET [2Fe-2S] clusters can be reversibly oxidized by hydrogen peroxide
Previous studies have shown that iron-sulfur clusters in regulatory proteins can undergo
redox transition in response to oxidative signals without disruption of the clusters (38-41). To
explore whether the mitoNEET [2Fe-2S] clusters may also act as a redox sensor to oxidative
signals, we examined the stability of the mitoNEET [2Fe-2S] clusters under oxidative stress
conditions. Figure 5.4 A shows that when purified mitoNEET [2Fe-2S] clusters were incubated
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with increasing concentrations of hydrogen peroxide (up to 50 fold excess), the UV-visible
absorption spectrum of the mitoNEET [2Fe-2S] clusters remained essentially unchanged,
indicating that the mitoNEET [2Fe-2S] clusters are stable in the presence of hydrogen peroxide,
yet are capable of being transiently oxidized.
We then questioned whether the pre-reduced mitoNEET [2Fe-2S] clusters can be oxidized
by hydrogen peroxide. To avoid possible effects of NADPH on the stability of the mitoNEET
[2Fe-2S] clusters (16), we pre-reduced the mitoNEET [2Fe-2S] clusters with excess dithiothreitol
under anaerobic conditions. As shown in Figure 5.4 B, the pre-reduced mitoNEET [2Fe-2S]
clusters were quickly oxidized upon addition of hydrogen peroxide. Further incubation with
dithiothreitol after the hydrogen peroxide treatment led to a full re-reduction of the oxidized
mitoNEET [2Fe-2S] clusters within about 14 minutes (Figure 5.4 B and C). The EPR
measurements of the protein samples taken from the reaction solution further confirmed that the
amount of the mitoNEET [2Fe-2S] clusters remain the same before and after the hydrogen
peroxide treatment (Figure 5.4 D), suggesting that the mitoNEET [2Fe-2S] clusters can undergo
redox transition in response to hydrogen peroxide without disruption of the clusters.
To further explore whether the mitoNEET [2Fe-2S] clusters could undergo redox transition
in vivo in response to hydrogen peroxide, the E. coli cells expressing the mitoNEET [2Fe-2S]
clusters were treated with hydrogen peroxide. As shown in Figure 5.5, addition of hydrogen
peroxide (1 mM) to the E. coli cells largely eliminated the EPR signal at g = 1.94 of the reduced
mitoNEET [2Fe-2S] clusters. Re-incubation of the E. coli cells in LB medium after the hydrogen
peroxide treatment quickly restored the EPR signal at g = 1.94 of the reduced mitoNEET [2Fe-2S]
clusters, demonstrating that the mitoNEET [2Fe-2S] clusters can undergo redox transition in
response to hydrogen peroxide in E. coli cells.
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Type II diabetes drug pioglitazone inhibits the thiol-mediated reduction of the mitoNEET
[2Fe-2S] clusters
It has been reported that binding of type II diabetes drug pioglitazone shifts the Em7 value
of the mitoNEET [2Fe-2S] clusters by -100 mV (11). The negative shift of the Em7 value would
make reduction of the mitoNEET [2Fe-2S] clusters more difficult. Nevertheless, how the redox
state of the mitoNEET [2Fe-2S] clusters may be modulated by pioglitazone is unknown. With the
finding that the mitoNEET [2Fe-2S] clusters can be reduced by biological thiols, we sought to
investigate the effect of pioglitazone on the thiol-mediated reduction of the mitoNEET [2Fe-2S]
clusters. Purified mitoNEET was pre-incubated with pioglitazone, followed by reduction with
thiols under anaerobic conditions. Figure 5.6 A shows that binding of pioglitazone had little or no

109

110

effect on the dithionite-mediated reduction of the mitoNEET [2Fe-2S] clusters, as dithionite is a
strong reductant (Em7 = -660 mV (27)). On the other hand, binding of pioglitazone largely inhibited
the dithiothreitol-mediated reduction of the mitoNEET [2Fe-2S] clusters (Figure 5.6 B). The
titration experiments show that as the concentration of pioglitazone was gradually increased in the
incubation solutions (from 0 to 2.5 mM), the amount of the dithiothreitol-reduced mitoNEET [2Fe2S] clusters was progressively decreased (Figure 5.6 C). We also tested whether pioglitazone
would affect the thioredoxin-mediated reduction of the mitoNEET [2Fe-2S] clusters in vitro. As
shown in Figure 5.6 D, binding of pioglitazone greatly inhibited the thioredoxin-mediated
reduction of the mitoNEET [2Fe-2S] clusters, suggesting that pioglitazone can effectively block
the biological thiol-mediated reduction of the mitoNEET [2Fe-2S] clusters in cells. Nevertheless,
attempts to modulate the redox state of the mitoNEET [2Fe-2S] clusters expressed in E. coli cells
with pioglitazone were not successful. This is likely because pioglitazone may not easily penetrate
bacterial cell walls and / or cell membranes, as addition of pioglitazone to the cell extracts prepared
from the E. coli cells effectively inhibits the thiol-mediated reduction of the mitoNEET [2Fe-2S]
clusters in the cell extracts (data not shown).

5.4 Discussion
In this study, we report that human mitoNEET [2Fe-2S] clusters are fully reduced when
expressed in E. coli cells under normal growth conditions, and that the clusters can be partially
reduced by monothiols and fully reduced by dithiothreitol and the E. coli thioredoxin / thioredoxin
reductase system in vitro. Importantly, the thiol-reduced mitoNEET [2Fe-2S] clusters can be
reversibly oxidized by hydrogen peroxide without disruption of the clusters. Furthermore, binding
of type II diabetes drug pioglitazone effectively blocks the thiol-mediated reduction of the
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mitoNEET [2Fe-2S] clusters. The results suggest that the mitoNEET [2Fe-2S] cluster may act as
a sensor of oxidative signals to regulate mitochondrial function and that the type II diabetes drug
pioglitazone may modulate the function of mitoNEET by blocking the thiol-mediated reduction of
the [2Fe-2S] clusters in cells. The possible interplay among biological thiols, hydrogen peroxide
and type II diabetes drug pioglitazone in regulating the redox state of the mitoNEET [2Fe-2S]
clusters is shown in Figure 5.7.

The interaction between thioredoxin and iron-sulfur clusters in proteins has been well
established in ferredoxin-thioredoxin reductase where the reduced iron-sulfur clusters provide
electrons for reduction of the oxidized thioredoxin (42,43). However, to the best of our knowledge,
reduction of iron-sulfur clusters in proteins by biological thiols has not been previously reported.
The unique ligand arrangement (Cys-72, Cys-74, Cys-83 and His-87) (8-10) and relatively high
Em7 value (~0 mV) (11,12) may facilitate the reduction of the mitoNEET [2Fe-2S] clusters by
biological thiols, as a single mutation (His-87 to cysteine) in mitoNEET shifts the Em7 value of the
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[2Fe-2S] clusters from ~0 to -320 mV (11) and effectively prevents reduction of the clusters by
biological thiols (Figure 5.3). Unlike NADPH which fails to reduce the mitoNEET [2Fe-2S]
clusters in vitro (21), biological thiols have a relatively stable intermediate state of a thiol free
radical (33,34) which can provide electrons for the single-electron reduction of the [2Fe-2S]
clusters in mitoNEET. Interestingly, monothiols such as reduced glutathione, L-cysteine and Nacetyl-L-cysteine can only partially reduce the mitoNEET [2Fe-2S] clusters even at high
concentrations and with extended incubation time. On the other hand, dithiothreitol (Figure 5.2)
and the E. coli thioredoxin pre-reduced with thioredoxin reductase and NADPH (Figure 5.3) can
fully reduce the mitoNEET [2Fe-2S] clusters. The redox reactions underlying the reduction of the
mitoNEET [2Fe-2S] clusters by biological thiols remain to be further investigated. Nevertheless,
the finding that the reduced thioredoxin can reduce the mitoNEET [2Fe-2S] clusters is highly
significant. Thioredoxin is highly conserved from bacteria to humans (36). In human cells, there
are two major thioredoxins: thioredoxin 1, which is located in the cytosol and nucleus, and
thioredoxin 2 located in mitochondria (44). The Em7 value of human cytosolic thioredoxin is about
-230 mV (45), which is close to that of E. coli thioredoxin (-270 mV) (37). Thus, human
thioredoxin could be responsible for reducing the mitoNEET [2Fe-2S] clusters. Because human
thioredoxin has an essential role in regulation of complex diseases including cancer (46),
cardiovascular disease, type II diabetes, and aging (47), the proposed role of human thioredoxin in
reducing the mitoNEET [2Fe-2S] clusters may provide fresh clues for the links between
thioredoxin and various human diseases. However, it should be pointed out that other biological
thiols such as glutathione, L-cysteine, and glutaredoxins (48) may also reduce the mitoNEET [2Fe2S] clusters in cells.
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As a novel target of type II diabetes drug pioglitazone, mitoNEET has a specific interaction
with pioglitazone (1). It has been speculated that pioglitazone may modulate energy metabolism
in mitochondria via direct interaction with mitoNEET (49). Previous studies indicated that binding
of pioglitazone stabilizes the [2Fe-2S] clusters in mitoNEET (10) and shifts the Em7 value of the
[2Fe-2S] clusters from ~0 mV to -100 mV (11). Here, we find that binding of pioglitazone
effectively inhibits the thiol-mediated reduction of the mitoNEET [2Fe-2S] clusters, likely due to
the decreased Em7 value of the [2Fe-2S] clusters in the protein. Thus, pioglitazone may alter the
function of mitoNEET by blocking the thiol-mediated reduction of the [2Fe-2S] clusters in cells.
A set of novel ligands have recently been identified that may target mitochondrial mitoNEET
(50,51). It would be of interest to explore the effect of these ligands on the thiol-mediated reduction
of the mitoNEET [2Fe-2S] clusters.
The finding that the mitoNEET [2Fe-2S] clusters can be reversibly oxidized by hydrogen
peroxide without disruption of the clusters strongly suggests that the mitoNEET [2Fe-2S] cluster
may act as a redox sensor to oxidative signals. The redox state of the [2Fe-2S] clusters in
mitoNEET has already been attributed to regulate the iron-sulfur cluster transfer from mitoNEET
to target proteins (20,21). It would be equally possible that the redox state of the [2Fe-2S] clusters
may directly modulate energy metabolism in mitochondria via specific protein-protein interactions
between mitoNEET and mitochondrial proteins such as pyruvate dehydrogenase in mitochondria
(49). In crystal structural models, mitoNEET exists as a homodimer with two mitoNEET
monomers tightly associated via the “beta cap” structure (8-10). The closest distance between the
two [2Fe-2S] clusters in the mitoNEET dimer is about 14 Å. We envision that when the reduced
[2Fe-2S] clusters are oxidized, two positive charges will be introduced to the mitoNEET dimer.
The electrostatic repulsion between the two [2Fe-2S] clusters in the mitoNEET dimer could lead
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to subtle conformation changes and consequently modulate mitochondrial functions. Similar redox
regulation of iron-sulfur clusters has been proposed for a number of proteins (40). For example, in
the redox transcription factor SoxR, oxidation of the [2Fe-2S] clusters switches on its transcription
activity (38,41). In the bacterial DNA damage-inducible DNA helicase DinG, the enzyme is active
only when the reduced [4Fe-4S] cluster is oxidized (39). In this context, we propose that
mitoNEET may represent a new member of this redox signaling protein family in human cells.
Genome-wide searching revealed that humans have at least two mitoNEET related
proteins: Miner1 (52) and Miner2 (2), which share the conserved CDGSH domain with mitoNEET
(53). Miner1 was initially localized in the endoplasmic reticulum (54), but a recent study indicated
that Miner1 is mostly associated with mitochondrial outer membrane (55). Mutations in the Miner1
gene have been attributed to Wolfram Syndrome 2, a disease characterized by juvenile onset
diabetes mellitus and optic atrophy (54). Biochemical studies have shown that Miner1 interacts
with BCL2 (B-cell lymphoma 2) (56) and regulates sulfhydryl redox status, the unfolded protein
response and Ca2+ homeostasis in mitochondria through an unknown mechanism (57). Like
mitoNEET, Miner1 hosts a [2Fe-2S] cluster via an unusual three cysteine and one histidine
residues in its C-terminal domain (52). While the function of Miner2 remains unknown, Miner2 is
also located on mitochondrial outer membrane and most likely contains a [2Fe-2S] cluster hosted
by three cysteine and one histidine residues (2). Existence of the [2Fe-2S] clusters in mitoNEET
(7), Miner1 (52) and most likely in Miner2 (2) strongly suggests that the [2Fe-2S] clusters in this
group of mitochondrial outer membrane proteins (53) may share similar and crucial regulatory
functions. If the [2Fe-2S] clusters in Miner1 and Miner2, like that in mitoNEET, can be reduced
by biological thiols and reversibly oxidized by hydrogen peroxide, Miner1 and Miner2 may also
act as redox sensors to modulate specific functions in response to oxidative signals in human cells.
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CHAPTER 6
REDUCTION OF HUMAN MITOCHONDRIAL PROTEIN MITONEET [2FE-2S]
CLUSTERS BY HUMAN GLUTATHIONE REDUCTASE 5

6.1 Introduction
Thiazolidinediones (TZDs) such as pioglitazone are prescription drugs for patients with
type II diabetes (1). While the primary target of TZDs is the peroxisome proliferator-activated
receptor γ (PPARγ) which regulates the expression of the genes for fatty acid metabolism and
insulin signaling pathways (2), TZDs also have the PPARγ-independent physiological effects on
energy metabolism in mitochondria (3). This observation led to the discovery of the novel
mitochondrial outer membrane protein mitoNEET, which specifically binds pioglitazone (4).
Deletion of mitoNEET in mice decreases the oxidative phosphorylation capacity in mitochondria
(5). On the other hand, increased expression of mitoNEET in adipocytes will enhance lipid uptake
and storage and inhibit mitochondrial iron transport into the matrix (6), suggesting that mitoNEET
may regulate energy metabolism in mitochondria (4). Recent studies further showed that
mitoNEET has a central role in development of neurodegenerative diseases (7), breast cancer
proliferation (8), TNFα-induced necroptosis in hepatocytes (9), and browning of white adipose
tissue (10), among other pathological conditions (11).
Human mitoNEET is a homodimer with each monomer containing an N-terminal
transmembrane α-helix (residues 14 to 32) tethered to mitochondrial outer membrane (5) and a Cterminal cytosolic domain hosting a redox active [2Fe-2S] cluster via the unusual ligand
arrangement of three cysteine (Cys-72, Cys-74 and Cys-83) and one histidine (His-87) residues
5

This chapter previously appeared as: Landry, A. P., Cheng, Z., and Ding, H. (2015) Reduction
of mitochondrial protein mitoNEET [2Fe-2S] clusters by human glutathione reductase. Free
radical biology & medicine 81, 119-127. Modified and reprinted with permission of Elsevier.
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(12-15). While the specific function of mitoNEET has not been fully understood, several studies
have suggested that mitoNEET may transfer its [2Fe-2S] clusters to apo-ferredoxin in vitro (16,17)
or to the iron regulatory protein-1 (IRP-1) in vivo (18). Since mitochondria are the primary sites
for iron-sulfur cluster biogenesis (19), it was compelling to suggest that mitoNEET may act as a
carrier transporting iron-sulfur clusters assembled in mitochondria to target proteins in cytoplasm
(16-18). Nevertheless, the observed cluster transfer occurs only when the mitoNEET [2Fe-2S]
clusters are in oxidized state (16). Since the redox midpoint potential of the mitoNEET [2Fe-2S]
clusters (Em7) is ~0 mV (20,21) and the cytosolic redox potential is ~ -325 mV (pH 7.0) (22), the
mitoNEET [2Fe-2S] clusters are mostly in the reduced state in cells under normal physiological
conditions (23). Thus, mitoNEET may transfer its iron-sulfur clusters to target proteins only when
cells are under oxidative stress conditions (16).
Alternatively, mitoNEET may directly regulate energy metabolism in mitochondria via its
redox active [2Fe-2S] clusters (20,23). It has already been reported that the redox property of the
mitoNEET [2Fe-2S] clusters can be modulated by pH (21), inter-domain interactions (24,25),
hydrogen bond network (26), type II diabetes drug pioglitazone (20), and NADP+/NADPH
(17,27). Recent proteomic studies further suggested that mitoNEET may form complexes with
proteins that are crucial in aging, diabetes, and neurodegenerative diseases (28,29). Thus, the
mitoNEET [2Fe-2S] cluster may act as a sensor of multiple cellular signals to regulate
mitochondrial functions through specific protein-protein interactions. In previous studies, we
reported that the mitoNEET [2Fe-2S] clusters are fully reduced when expressed in Escherichia
coli cells, and that purified mitoNEET [2Fe-2S] clusters can be reduced by dithiothreitol or the E.
coli thioredoxin/thioredoxin reductase system (23). However, specific components that reduce or
oxidize the mitoNEET [2Fe-2S] clusters in mammalian cells have not been identified. Here, we
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find that human mitoNEET [2Fe-2S] clusters can be efficiently reduced by E. coli thioredoxin
reductase and glutathione reductase in an NADPH-dependent reaction. Purified human glutathione
reductase (30) has the same activity as E. coli glutathione reductase to reduce the mitoNEET [2Fe2S] clusters. However, rat thioredoxin reductase, a human thioredoxin reductase homolog that
contains an unusual selenocysteine residue (U498) in the catalytic center (31-33), has very little or
no activity to reduce the mitoNEET [2Fe-2S] clusters. N-ethylmaleimide, a potent modifier of
redox active thiols in human glutathione reductase (34), completely inhibits the enzyme to reduce
the mitoNEET [2Fe-2S] clusters, indicating that the redox active disulfide in the catalytic center
of human glutathione reductase may be directly involved in reducing the mitoNEET [2Fe-2S]
clusters. Additional studies show that the reduced mitoNEET [2Fe-2S] clusters in the mouse heart
cell extracts can be reversibly oxidized by hydrogen peroxide. The results led us to propose that
the mitoNEET [2Fe-2S] clusters may act as a novel redox sensor to modulate energy metabolism
in mitochondria in response to oxidative signals.

6.2 Materials and Methods
Protein preparation
A DNA fragment encoding human mitoNEET33–108 (containing amino acid residues 33108) was synthesized (Genscript) and cloned into pET28b+. Recombinant mitoNEET was
expressed in the E. coli BL21(DE3) strain and purified as described previously (23,35). E. coli
thioredoxin reductase (36), glutathione reductase (37), succinic semialdehyde dehydrogenase (38),
and 2,4-dienoyl-CoA reductase (39) were prepared using the E. coli strains from the ASKA library
(40). Recombinant human glutathione reductase was prepared using the plasmid pUB302 (kindly
provided by Professor Katja Becker, Justus Liebig University, Germany) in an E. coli strain SG5
(in which gene gor encoding glutathione reductase was deleted) (41). E. coli strain SG5 cells
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hosting pUB302 were grown in LB medium at 37°C for 5 hours without inducers, harvested, and
disrupted by passing through French press once. The crude cell extracts were centrifuged at 12,000
x g for 30 minutes at 4°C to remove cell debris. The supernatant was dialyzed against 20 mM Tris
(pH 8.0) for 5 hours at 4°C. The dialyzed sample was supplemented with 1 mM oxidized
glutathione (GSSG) and loaded onto an ADP-Sepharose column and washed with 0.3 M NaCl.
Human glutathione reductase was then eluted from the column with 0.8 M NaCl and stored in 0.5
M NaCl. The purity of purified proteins was greater than 95% as judged by SDS-PAGE analysis
on a 15% polyacrylamide gel followed by staining with Coomassie Blue. The protein
concentrations of human mitoNEET, E. coli thioredoxin reductase, E. coli glutathione reductase,
and human glutathione reductase were measured at 280 nm using an extinction coefficient of 8.6,
17.7, 38.2, and 34.9 mM-1cm-1, respectively. Native rat liver thioredoxin reductase was purchased
from Sigma. Recombinant rat thioredoxin reductase (containing the native selenocysteine in the
catalytic center) (42) was purchased from Cayman Chemical.
Cell extracts preparation from E. coli cells and mouse heart
Wildtype E. coli BL21(DE3) cells were grown in LB medium at 37°C under aerobic
conditions to O.D. at 600 nm of 1.0. Cells were harvested, washed with buffer containing NaCl
(500 mM) and Tris (20 mM, pH 8.0), and passed through French press once. After centrifugation
at 8,000 x g for 30 minutes at 4°C to remove cell debris, the resulting supernatant was passed
through a HiTrap desalting column (GE Lifesciences). For the mouse heart cell extracts, hearts
from wildtype mice (C57BL/6J, 3-4 weeks old, obtained from Pennington Biomedical Research
Center, Louisiana State University) were rinsed in PBS buffer and minced with scissors. Heart
tissues were ground with a homogenizer and further disrupted by drawing and ejecting samples
using a syringe with a 26-gauge needle. Cell debris were removed by centrifugation at 8,000 x g
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for 20 minutes at 4°C, and the resulting supernatant was used for the experiments. The protein
concentration of the prepared cell extracts was determined using Bradford assay (43).
Analyses of the redox state of mitoNEET [2Fe-2S] clusters
Purified human mitoNEET dissolved in buffer containing NaCl (500 mM) and Tris (20
mM, pH 8.0) in a sealed vial was purged with pure argon gas for 15 minutes. The prepared cell
extracts or enzymes were also purged with pure argon gas before transferred to the sealed vials
using a gas-tight Hamilton syringe. The reaction solutions were then incubated in a 37°C water
bath for the indicated time before the samples were analyzed by using the Beckman DU640 UVvisible spectrophotometer or EPR. For the N-ethylmaleimide (NEM) treatments, purified human
glutathione reductase or the mouse heart cell extracts were pre-incubated with NEM (2 mM) and
NADPH (0.2 mM) at room temperature for 3 hours to irreversibly modify the redox active thiols
in the proteins.
EPR measurements
The X-band EPR (electron paramagnetic resonance) spectra were recorded using a Bruker
model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow cryostat.
Routine EPR conditions were: microwave frequency, 9.47 GHz; microwave power, 10.0 mW;
modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 30 K; receive gain,
2 x 105. The amount of the reduced mitoNEET [2Fe-2S] clusters was quantified as in (23).
Chemicals
Isopropyl

β-D-1-thiogalactopyranoside,

NADPH,

kanamycin,

ampicillin,

and

dithiothreitol were purchased from Research Products International. Pioglitazone, reduced
glutathione, oxidized glutathione, N-ethylmaleimide, hydrogen peroxide, and other chemicals
were purchased from Sigma.
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6.3 Results
Reduction of the mitoNEET [2Fe-2S] clusters by E. coli thioredoxin reductase and
glutathione reductase
When recombinant human mitoNEET was expressed in E. coli cells, the mitoNEET [2Fe2S] clusters were fully reduced (23), indicating that E. coli cells have a robust activity to reduce
the mitoNEET [2Fe-2S] clusters. To search for the cellular components that are responsible for
reducing the human mitoNEET [2Fe-2S] clusters, we prepared cell extracts from exponentially
growing E. coli cells. Figure 6.1 A shows that while NADPH (spectrum 2) or the E. coli cell
extracts (spectrum 3) had no activity to reduce the human mitoNEET [2Fe-2S] clusters, addition
of NADPH to the cell extracts quickly reduced the mitoNEET [2Fe-2S] clusters (spectrum 4)
which had a typical rhombic EPR signal at g = 1.94 (12,23,26). The amplitude of the EPR signal
at g = 1.94 of the mitoNEET [2Fe-2S] clusters in the E. coli cell extracts (spectrum 4) was
essentially the same as that when the mitoNEET protein was reduced with sodium dithionite
(spectrum 5), indicating that the mitoNEET [2Fe-2S] clusters are fully reduced in the E. coli cell
extracts by NADPH.
Since the mitoNEET [2Fe-2S] clusters can be reduced by excess dithiothreitol in vitro (23),
we reasoned that the mitoNEET [2Fe-2S] clusters may be reduced by reduced thioredoxin (23) or
the enzymes that contain a redox active disulfide in vivo. In E. coli, there are at least two reductases:
thioredoxin reductase (44) and glutathione reductase (37), that have a redox active disulfide in the
catalytic center. To test this idea, we prepared E. coli thioredoxin reductase and glutathione
reductase as described in the Materials and Methods. Purified E. coli thioredoxin reductase and
glutathione reductase had a similar UV-visible absorption spectrum (Figure 6.1 B), indicative of
the protein-bound FAD cofactor as reported previously (37,44).
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Figure 6.1. MitoNEET [2Fe-2S] clusters are reduced by E. coli thioredoxin reductase and glutathione
reductase. A, EPR spectra of the mitoNEET [2Fe-2S] clusters in the E. coli cell extracts. Purified mitoNEET
(10 μM [2Fe-2S] clusters; spectrum 1) was incubated with NADPH (50 μM; spectrum 2), the E. coli cell
extracts (4 mg/ml of total protein; spectrum 3), or NADPH (50 μM) and the E. coli cell extracts (4 mg/ml
of total protein; spectrum 4) at 37°C for 20 min under anaerobic conditions. Spectrum 5, purified mitoNEET
(10 μM [2Fe-2S] clusters) reduced with 2 mM sodium dithionite. The EPR signal at g = 1.94 represents the
reduced mitoNEET [2Fe-2S] clusters. B, Purified E. coli thioredoxin reductase and glutathione reductase.
Spectrum 1, UV-visible absorption spectrum of purified E. coli thioredoxin reductase (eTrxB). Spectrum
2, UV-visible absorption spectrum of purified glutathione reductase (eGor). eTrxB and eGor shown in B
contained about 15 μM FAD. Inset is a photograph of the SDS-PAGE of purified E. coli thioredoxin
reductase (lane 1) and glutathione reductase (lane 2). C, Reduction of the mitoNEET [2Fe-2S] clusters by E.
coli thioredoxin reductase and glutathione reductase. Purified mitoNEET (10 μM [2Fe-2S] clusters;
spectrum 1) was incubated with NADPH (50 μM; spectrum 2), eTrxB (1 μM; spectrum 3), eGor (1 μM;
spectrum 4), E. coli thioredoxin reductase (1 μM) and NADPH (50 μM; spectrum 5), or E. coli glutathione
reductase (1 μM) and NADPH (50 μM; spectrum 6) at 37°C for 20 min under anaerobic conditions. The
EPR signal at g = 1.94 represents the reduced mitoNEET [2Fe-2S] clusters. The results are representatives
of three independent experiments.
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Figure 6.1 C shows that purified E. coli thioredoxin reductase (spectrum 3) or glutathione
reductase (spectrum 4) had no activity to reduce the mitoNEET [2Fe-2S] clusters. However, when
mitoNEET was incubated with E. coli thioredoxin reductase and NADPH (spectrum 5) or E. coli
glutathione reductase and NADPH (spectrum 6) at 37°C for 20 minutes under anaerobic
conditions, the mitoNEET [2Fe-2S] clusters were fully reduced, suggesting that both E. coli
thioredoxin reductase and glutathione reductase are able to reduce the mitoNEET [2Fe-2S] clusters
in the presence of NADPH. In parallel, we also prepared two NADPH-dependent reductases:
succinic semialdehyde dehydrogenase (38) and 2,4-dienoyl-CoA reductase (39) from E. coli cells.
Both enzymes use NADPH as a substrate but do not contain the redox active disulfide in the
catalytic center. Under the same experimental conditions, E. coli succinic semialdehyde
dehydrogenase and 2,4-dienoyl-CoA reductase had no activity to reduce the mitoNEET [2Fe-2S]
clusters in the presence of NADPH (data not shown). Thus, E. coli thioredoxin reductase and
glutathione reductase activity in reducing the human mitoNEET [2Fe-2S] clusters is specific.
Reduction of the mitoNEET [2Fe-2S] clusters by human glutathione reductase
In humans, there are three thioredoxin reductases: a cytosolic form (45), a mitochondrial
form (46), and a thioredoxin / glutathione reductase in the microsomal fraction of testis tissue (47).
As mitoNEET localizes on mitochondrial outer membrane (5), it is most likely that cytosolic
thioredoxin reductase would be responsible for reducing the mitoNEET [2Fe-2S] clusters. Like E.
coli thioredoxin reductase, human cytosolic thioredoxin reductase contains FAD and an NADPH
binding site (32,33,48). However, unlike E. coli thioredoxin reductase, human thioredoxin
reductase has an unusual selenocysteine residue (U498) in the catalytic center (31-33). As native
human cytosolic thioredoxin reductase was not readily available, we used rat thioredoxin reductase
which has 91% identity and 96% similarity to human thioredoxin reductase and contains the
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selenocysteine residue in the catalytic center. Rat liver thioredoxin reductase (from Sigma) was
fully active to reduce 5,5´-dithiobis-(2-nitrobenzoic acid) (DTNB). However, unlike E. coli
thioredoxin reductase, rat liver thioredoxin reductase had very little or no activity to reduce the
mitoNEET [2Fe-2S] clusters (data not shown). We also obtained recombinant rat thioredoxin
reductase (from Cayman Chemical) which also contains the selenocysteine residue and is fully
active to reduce DTNB (42). As before, recombinant rat thioredoxin reductase failed to reduce the
mitoNEET [2Fe-2S] clusters in the presence of NADPH (Figure 6.2 B, spectrum 2).
Human glutathione reductase is a major cellular reductase that reduces the oxidized
glutathione in cytosol (30,41). Unlike human thioredoxin reductase, human glutathione reductase
does not have selenocysteine in the catalytic center. Thus, we prepared recombinant human
glutathione reductase from E. coli cells following the procedures described in (41). Purified human
glutathione reductase had a similar UV-visible absorption spectrum as E. coli glutathione reductase
(Figure 6.2 A), and similar activity to reduce the mitoNEET [2Fe-2S] clusters in the presence of
NADPH (Figure 6.2 B, spectra 3 and 4). Therefore, in human cells, glutathione reductase is at least
one protein able to reduce the mitoNEET [2Fe-2S] clusters in an NADPH-dependent reaction.
Pioglitazone, a type II diabetes drug, has been shown to shift the redox midpoint potential
(Em7) of the mitoNEET [2Fe-2S] clusters by ~ -100 mV (20). The negative shift of the Em7 value
would make it more difficult to reduce the mitoNEET [2Fe-2S] clusters. It would be of interest to
know whether pioglitazone affects the human glutathione reductase-mediated reduction of the
mitoNEET [2Fe-2S] clusters. Thus, mitoNEET was pre-incubated with pioglitazone before being
reduced with human glutathione reductase and NADPH. As shown in Figure 6.2 B, the mitoNEET
[2Fe-2S] clusters were only partially inhibited (spectrum 5) upon binding of pioglitazone. The
result is consistent with the notion that binding of pioglitazone to mitoNEET negatively shifts the
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Em7 of the mitoNEET [2Fe-2S] clusters (20,23) and impedes reduction of the mitoNEET [2Fe-2S]
clusters by glutathione reductase.
The oxidized mitoNEET [2Fe-2S] clusters have two major UV-visible absorption peaks at
458 nm and 540 nm (12). When the mitoNEET [2Fe-2S] clusters are reduced, the absorption peak
at 458 nm is changed to 420 nm (23). Here, we took advantage of these distinct UV-visible
absorption peaks of the mitoNEET [2Fe-2S] clusters to explore the reduction kinetics of the
mitoNEET [2Fe-2S] clusters by human glutathione reductase. When mitoNEET was incubated
with a catalytic amount of human glutathione reductase in the presence of NADPH at 37°C under
anaerobic conditions, the absorption peak at 458 nm of the oxidized mitoNEET [2Fe-2S] clusters
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was quickly decreased and replaced with the absorption peak at 420 nm of the reduced mitoNEET
[2Fe-2S] clusters (Figure 6.3 A). The amount of the reduced mitoNEET [2Fe-2S] clusters in the
reaction solution was plotted as a function of incubation time. Under the experimental conditions,
the mitoNEET [2Fe-2S] clusters were fully reduced by 20 minutes with a half-reduction time of
less than 5 minutes (Figure 6.3 B).

The redox active disulfide center in human glutathione reductase is involved in reducing the
mitoNEET [2Fe-2S] clusters
Human glutathione reductase catalyzes the reduction of oxidized glutathione (GSSG) to
reduced glutathione (GSH) using NADPH as electron donor (30,41). If glutathione reductase
reduces the mitoNEET [2Fe-2S] clusters at the same catalytic site where GSSG is reduced, we
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would expect competition between GSSG and the mitoNEET [2Fe-2S] clusters for the catalytic
center in the enzyme. To test this idea, we explored the effect of GSSG on the glutathione
reductase-mediated reduction of the mitoNEET [2Fe-2S] clusters. Figure 6.4 A shows that in the
absence of GSSG, the mitoNEET [2FE-2S] clusters (10 μM) were fully reduced by 10 μM NADPH
in the presence of a catalytic amount of human glutathione reductase. In the presence of 10 μM
GSSG, however, the mitoNEET [2Fe-2S] clusters were reduced only after 20 μM NADPH was
added in the incubation solution (Figure 6.4 B). Thus, GSSG may effectively block the human
glutathione reductase-mediated reduction of the mitoNEET [2Fe-2S] clusters by competing for the
same catalytic center in the enzyme (Figure 6.4 C).
Unlike E. coli thioredoxin reductase and glutathione reductase (Figure 6.1 C) or human
glutathione reductase (Figure 6.2 B), rat thioredoxin reductase has very little or no activity to
reduce the mitoNEET [2Fe-2S] clusters (Figure 6.2 B). One possible explanation is that rat
thioredoxin reductase has an unusual selenocysteine in the catalytic center (31-33), which fails to
reduce the mitoNEET [2Fe-2S] clusters. If that is the case, we would expect that modification of
the redox active disulfide in the catalytic center of human glutathione reductase may inhibit the
enzyme activity to reduce the mitoNEET [2Fe-2S] clusters.
N-ethylmaleimide (NEM), a potent thiol modifier, has been used to inhibit human
glutathione reductase (34,49). Figure 6.4 D shows that the NEM-treated human glutathione
reductase failed to reduce the mitoNEET [2Fe-2S] clusters (spectrum 2). However, addition of
sodium dithionite to the above reaction solution quickly restored the EPR signal at g = 1.94 of the
mitoNEET [2Fe-2S] clusters (spectrum 3), suggesting that NEM inhibits human glutathione
reductase to reduce the mitoNEET [2Fe-2S] clusters without directly modifying the mitoNEET
[2Fe-2S] clusters or the protein itself to inhibit reduction. Thus, the redox active disulfide in the
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catalytic center of human glutathione reductase may be directly involved in in reducing the
mitoNEET [2Fe-2S] clusters.
The mitoNEET [2Fe-2S] clusters are fully reduced in the mouse heart cell extracts by
NADPH
As human glutathione reductase can efficiently reduce the mitoNEET [2Fe-2S] clusters in
an NADPH-dependent reaction (Figure 6.3), the mitoNEET [2Fe-2S] clusters may also be reduced
in mammalian cells by glutathione reductase or similar enzymes. To test this idea, we prepared
cell extracts from mouse heart as described in the Materials and Methods. Figure 6.5 A shows that
while the mouse heart cell extracts had no activity to reduce the mitoNEET [2Fe-2S] clusters
(spectrum 2), addition of NADPH to the cell extracts reduced the mitoNEET [2Fe-2S] clusters
(spectrum 3) with the EPR amplitude similar to that reduced with sodium dithionite (spectrum 4).
The cell extracts were then treated with the thiol modifier NEM to inactivate glutathione
reductase or similar enzymes. As shown in Figure 6.5 B, the NEM-treated cell extracts had no
activity to reduce the mitoNEET [2Fe-2S] clusters in the presence of NADPH (spectrum 3).
Nevertheless, addition of sodium dithionite to the NEM-treated cell extracts immediately restored
the EPR signal at g = 1.94 of the reduced mitoNEET [2Fe-2S] clusters (spectrum 4), suggesting
that NEM inhibits the cellular reductase activities without affecting on the mitoNEET [2FE-2S]
clusters in the mouse heart cell extracts.
Reduced mitoNEET [2Fe-2S] clusters in the cell extracts are transiently oxidized by
hydrogen peroxide
To examine whether the mitoNEET [2Fe-2S] clusters may undergo redox transition in
response to oxidative signals, we treated mouse heart cell extracts containing the pre-reduced
mitoNEET [2Fe-2S] clusters with different amounts of hydrogen peroxide. As the concentration
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of hydrogen peroxide in the cell extracts was increased from 0 to 200 μM, the reduced mitoNEET
[2Fe-2S] clusters were gradually oxidized (Figure 6.6 A). About 100 μM hydrogen peroxide was
sufficient to completely oxidize 5 μM mitoNEET [2Fe-2S] clusters in the cell extracts (Figure 6.6
B). Importantly, addition of sodium dithionite to the hydrogen peroxide-treated cell extracts
quickly restored the EPR signal at g = 1.94 of the reduced mitoNEET [2Fe-2S] clusters (Figure
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6.6 A), suggesting that hydrogen peroxide oxidizes the mitoNEET [2Fe-2S] clusters without
disrupting the clusters in the protein.
We then asked whether oxidation of the mitoNEET [2Fe-2S] clusters by hydrogen peroxide
is reversible in the mouse heart cell extracts. In the experiment, the mitoNEET [2Fe-2S] clusters
oxidized by hydrogen peroxide in the cell extracts with excess NADPH were re-incubated at 37°C
under anaerobic conditions. As shown in Figure 6.7, the oxidized mitoNEET [2Fe-2S] clusters in
the cell extracts were almost fully re-reduced within about 30 minutes of re-incubation after the
initial oxidation of the clusters by hydrogen peroxide.

136

6.4 Discussion
Human mitoNEET is a small mitochondrial outer membrane protein containing a redox
active [2Fe-2S] cluster. Here we find that the mitoNEET [2Fe-2S] clusters can be efficiently
reduced by human glutathione reductase in an NADPH-dependent reaction. On the other hand, rat
thioredoxin reductase, a homolog of human thioredoxin reductase, has very little or no activity to
reduce the mitoNEET [2Fe-2S] clusters. Oxidized glutathione appears to compete for the catalytic
site of human glutathione reductase and effectively inhibits the enzyme-mediated reduction of the
mitoNEET [2Fe-2S] clusters, indicating a potential dynamic link between the redox state of the
137

mitoNEET [2Fe-2S] clusters and the ratio of oxidized glutathione to reduced glutathione in cells.
Additional studies further revealed that the reduced mitoNEET [2Fe-2S] clusters in the mouse
heart cell extracts can be transiently oxidized by hydrogen peroxide without disruption of the
clusters in the protein. The results suggest that the mitoNEET [2Fe-2S] clusters may undergo redox
transition to regulate energy metabolism in mitochondria in response to oxidative signals.
The finding that human glutathione reductase (30) can reduce the mitoNEET [2Fe-2S]
clusters (Figure 6.2 B) is novel. While the underlying mechanism is not immediately clear, it seems
that the redox active disulfide in the catalytic center of human glutathione reductase has a crucial
role in reducing the mitoNEET [2Fe-2S] clusters. Both E. coli thioredoxin reductase (44) and
glutathione reductase (37) contain redox active disulfide in the catalytic center and have the same
activity to reduce the mitoNEET [2Fe-2S] clusters (Figure 6.1). In contrast, rat thioredoxin
reductase, a homolog of human thioredoxin reductase that contains an unusual selenocysteine in
the catalytic center (31-33), has very little or no activity to reduce the mitoNEET [2Fe-2S] clusters
(Figure 6.2 B). E. coli succinic semialdehyde dehydrogenase (38) and 2,4-dienoyl-CoA reductase
(39), which use NADPH as substrate but do not have a redox active disulfide in the catalytic center,
also fail to reduce the mitoNEET [2Fe-2S] clusters (data not shown). Furthermore, modification
of the redox active disulfide in human glutathione reductase by thiol modifier NEM (34,49)
completely inhibits the enzyme activity to reduce the mitoNEET [2Fe-2S] clusters (Figures 6.4
and 6.5). Taken together, we conclude that the redox active disulfide in the catalytic center of
human glutathione reductase may be directly involved in reducing the mitoNEET [2Fe-2S] clusters
(Figure 6.8).
While the mechanism for reduction of dithiol by iron-sulfur cluster in proteins has been
extensively investigated in plant ferredoxin-thioredoxin reductase (50), the reverse reaction
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(reduction of iron-sulfur cluster in proteins by monothiol) is essentially unknown. Interestingly,
Fridovich’s group previously reported that E. coli thioredoxin reductase may produce superoxide
by transferring a single electron to dioxygen (51). Perhaps, E. coli thioredoxin reductase utilizes
similar mechanism to reduce the mitoNEET [2Fe-2S] clusters (Figure 6.1 C). More recently,
Buckel’s group showed that butyryl-CoA dehydrogenase from Acidaminococcus fermentans, a
FAD-containing enzyme, can reduce the ferredoxin [4Fe-4S] cluster and crotonyl-CoA
simultaneously (52) in a bifurcation reaction (53). FAD acts as an electron gate to deliver one
electron at a time for reduction of the ferredoxin [4Fe-4S] cluster and crotonyl-CoA in butyrylCoA dehydrogenase (52). As human glutathione reductase also contains FAD (Figure 6.2 A), we
propose that during the reaction cycle, an intermediate state of FADH- coupled with the redox
active disulfide formed in human glutathione reductase (30) may deliver single electrons to reduce
the mitoNEET [2Fe-2S] clusters (Figure 6.8).
Under normal physiological conditions, the mitoNEET [2Fe-2S] clusters are mostly in
reduced state in vivo (23) (Figure 6.5). However, when cells are under oxidative stress or during
apoptosis and differentiation, the intracellular redox potential could increase from -325 mV (pH
7.0) (22) to as high as +200 mV (54), which would result in oxidation of the mitoNEET [2Fe-2S]
clusters. The closest distance between two [2Fe-2S] clusters in the mitoNEET dimer is about 14
Å (13-15). Thus, oxidation of the two [2Fe-2S] clusters in the mitoNEET dimer may result in
confirmation change of the mitoNEET dimer via electric repulsion. Since mitoNEET can
potentially form protein complexes with E3 ubiquitin ligase Parkin (28), V-ATPase (29), taxresponsive enhancer element-binding protein 107 (RPL6) (29), translocase of outer mitochondrial
membrane 7 homolog (TOMM7) (29), mitochondrial outer membrane import complex protein 1
(MTX1) (29), polyubiquitin-C (UBC) (55), and glutamate dehydrogenase 1 (56), we postulate that
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mitoNEET may modulate the functions of its binding partners in mitochondria via redox transition
of its [2Fe-2S] clusters in response to redox signals.
MitoNEET-like proteins are widely distributed in the three domains of life (57-59). In
humans, there are two mitoNEET-like proteins: Miner1 (60) and Miner2 (5). Like mitoNEET, the
C-terminal domain of Miner1 hosts a redox active [2Fe-2S] cluster via three cysteine and one
histidine residues (60). Mutations in Miner1 have been attributed to Wolfram Syndrome 2, a
disease characterized by juvenile onset diabetes mellitus and optic atrophy (61). Miner1 was
initially localized on endoplasmic reticulum (61), but recent studies indicated that Miner1 also
localizes on mitochondrial outer membrane (62,63) and has a crucial role in regulating sulfhydryl
redox status, the unfold protein response, and Ca2+ homeostasis in mitochondria via a yet unknown
regulatory mechanism (63). While the physiological function of Miner2 remains unknown, Miner2
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is also a mitochondrial outer membrane protein (5) hosting two [2Fe-2S] clusters per monomer
(unpublished results). It may be envisioned that human mitoNEET, Miner1, and Miner2 may
modulate different functions on mitochondria via redox transition of the [2Fe-2S] clusters.
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CHAPTER 7
CONCLUSIONS AND FUTURE DIRECTIONS

Iron-sulfur cluster biogenesis is comprised of a complex protein system that first requires
the acquisition of sulfur and iron. The source of sulfur for iron-sulfur cluster assembly in E. coli is
provided by the cysteine desulfurase IscS, which extracts sulfide from L-cysteine. However, an
iron donor for the iron-sulfur cluster assembly process has not been established. Previous evidence
suggests that IscA could participate as the iron donor for iron-sulfur cluster assembly (1). Here,
we have demonstrated that among the basal iron-sulfur cluster assembly machinery of IscS, IscU
and IscA and co-chaperones HscB and HscA, significant iron content was only detected in IscA
after purification from E. coli cells, and the iron content of IscA was increased by reconstitution
with ferrous iron. Previously, L-cysteine was found to extract iron from IscA (2). In this study, the
iron release from IscA was found to be a two-step mechanism of 1) L-cysteine-mediated extraction
of Fe3+ from IscA and 2) L-cysteine-mediated reduction of Fe3+ to Fe2+ for use in the iron-sulfur
cluster assembly process. IscA contains a 3-cysteine binding pocket which can either harbor iron
or an iron-sulfur cluster (3,4). However, we also investigated IscA tyrosine 40 (Y40) as a potential
oxygenic ligand for iron binding (5). Mutation of tyrosine 40 to phenylalanine (Y40F) greatly
diminished iron binding in IscA. Interestingly, IscA Y40F can still assemble iron sulfur clusters
but fails to rescue the null growth phenotype in iscA-/sufA- mutant E. coli cells. Thus, iron-sulfur
cluster binding in IscA is dispensable for its function, but iron binding in IscA is required in vivo.
Recently, iscA-/sufA- mutant E. coli cells were found to generate a unique red-colored IscS,
and this species was also formed by depleting wildtype E. coli cells of iron (6). This indicated that
red IscA that may represent a reaction intermediate, and suggested that iron binding in IscA is
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required for proper IscS function. Investigating other reaction intermediates in the iron-sulfur
cluster assembly process will be the next step in determining the function of iron-bound IscA.
Iron-sulfur proteins are susceptible to nitric oxide (NO), which modifies the iron-sulfur
cluster and can compromise protein function. NO modification of iron-sulfur clusters results in the
formation of intracellular dinitrosyl iron complexes (DNICs). However, the protein source of in
vivo DNIC formation was unclear. Here, we demonstrated that the DNICs generated in the cell are
concomitant with the presence of iron-sulfur proteins, as expression of recombinant iron-sulfur
proteins in E. coli cells significantly increased DNICs formed after NO treatment. In contrast,
recombinant proteins that do not contain iron-sulfur clusters did not contribute to DNICs formed
after NO treatment. Furthermore, E. coli iscA-/sufA- double mutant cells generated very little
DNICs after NO treatment compared to wildtype cells, and DNIC formation in the mutant was not
increased by the expression of recombinant iron-sulfur proteins. Chelating iron from E. coli cells
resulted in loss of iron-sulfur clusters from cells and diminished DNIC formation after NO
treatment. Deficiency of iron-sulfur clusters was also found to decrease chelatable iron in the iscA/sufA- double mutant cells. Taken together, these results show that iron-sulfur proteins are a
significant source of intracellular chelatable iron and may be a primary target of NO cytotoxicity.
As iron-sulfur proteins are the primary source of DNICs formed from NO stress, it would
be intriguing to investigate the specific iron-sulfur proteins modified by NO in vivo. Previous
studies from our lab have demonstrated a broad distribution of DNICs in proteins fractionated from
E. coli cell extract (7). DNIC modification may also be very dynamic depending on the level of
NO exposure to cells, as some iron-sulfur clusters react with NO with higher affinity than others
(8). Thus, exploring the iron-sulfur cluster proteins modified by NO in vivo could provide insight
into the specific protein targets of NO cytotoxicity.
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Several diseases have been attributed to dysfunctional iron-sulfur proteins including Rtel1,
a DNA helicase that maintains telomere length. Rtel1 was predicted to contain an iron-sulfur
cluster that may modulate its helicase activity similar to E. coli DinG, a redox active [4Fe-4S]
DNA damage-inducible helicase (9). Here, we have identified a [4Fe-4S] cluster in the N-terminal
domain of Rtel1 (RtelN). The cluster is redox-active with a redox midpoint potential of -248 ± 10
mV, suggesting the cluster may be in the reduced state in vivo. RtelN also retains weak binding
affinity for both single-stranded and double-stranded DNA. The [4Fe-4S] cluster was sensitive to
destruction by both hydrogen peroxide and NO modification, although neither affected the DNA
binding activity. From the results, we speculate that Rtel1 may have a redox-dependent activity
similar to DinG, in which the reduced [4Fe-4S] cluster can be oxidized to activate helicase activity.
Although a redox-active [4Fe-4S] cluster is present, the function of the cluster in Rtel1
helicase activity remains to be determined. Our attempts to purify Rtel1 were restricted by its low
solubility when expressed as a full-length recombinant protein in E. coli; thus, any further
characterization of Rtel1 will require the development of a novel purification process. If soluble
protein can be attained, it can readily be assayed for redox-dependent helicase activity. Telomeres
are more susceptible to oxidative stress than other chromosomal DNA (10); thus, elucidating a
redox-dependent helicase mechanism in Rtel1 would reveal a new link between telomere
breakdown, oxidative stress, and aging.
The human [2Fe-2S] protein MitoNEET is a binding target of the type II diabetes drug
pioglitazone (11) and has implications in mitochondrial metabolism and diabetes. However, the
functional role for mitoNEET is unclear. Here, we have demonstrated that when expressed in E.
coli cells, the mitoNEET [2Fe-2S] clusters are in the reduced state. In vitro, the oxidized
mitoNEET [2Fe-2S] cluster was efficiently reduced by biological thiols including L-cysteine,
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glutathione and N-acetyl-L-cysteine, as well as dithiothreitol and the E. coli thioredoxin /
thioredoxin reductase system. This is a novel mechanism of iron-sulfur cluster reduction and is
reversible, as hydrogen peroxide transiently oxidized the clusters in vitro and in vivo. The thiolmediated reduction of mitoNEET [2Fe-2S] clusters was disrupted by pioglitazone binding to the
protein, likely due to the concomitant decrease in the [2Fe-2S] redox midpoint potential.
Because the reduction of mitoNEET [2Fe-2S] clusters could be facilitated by E. coli cell
extracts with NADPH or E. coli thioredoxin reductase with NADPH, we speculated that there may
be human proteins that enzymatically reduce mitoNEET. We found that cytoplasmic human
glutathione reductase (hGSR) is capable of reducing the mitoNEET [2Fe-2S] clusters in an
NADPH-dependent manner. Oxidized glutathione can compete against the mitoNEET [2Fe-2S]
clusters for reduction by hGSR, and N-ethylmaleimide (NEM) modification of the active site
abolished the hGSR activity to reduce the mitoNEET [2Fe-2S] clusters. These results correlated
with those obtained using mouse heart cell extracts, which could reduce the mitoNEET [2Fe-2S]
clusters in the presence of NADPH but failed to do so after pre-treatment with NEM. MitoNEET
[2Fe-2S] clusters in the mouse heart cell extracts could be transiently oxidized by hydrogen
peroxide. Taken together, these results demonstrate that mitoNEET may act as a sensor of
intracellular redox status.
Based on the current findings, it would be of interest to investigate [2Fe-2S] redox
transitions in membrane-bound mitoNEET which is more representative of its native state. We
have recently constructed a hybrid of mitoNEET fused to an E. coli membrane domain to allow
recombinant expression of mitoNEET that mimics its native state. The fusion protein is predicted
to have similar redox properties as the truncated protein, but it may have a stronger affinity for
pioglitazone, as the drug is hydrophobic and may have favorable interactions with membrane-
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bound mitoNEET. Several membrane-associated proteins have also been observed to interact with
mitoNEET (12-16); thus, membrane-bound mitoNEET may also improve the quality of protein
interaction studies. We speculate that the redox state of mitoNEET may influence the functions
these binding partners to constitute a novel redox signaling mechanism, and pioglitazone binding
to mitoNEET may disrupt this communication to produce its antidiabetic effects.
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